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Foreword 
 
 
 
Community pharmacists have always played a significant role in promoting, 
maintaining and improving the public’s health.  Based at the heart of communities, 
they gain a unique understanding of the health needs of the communities they 
serve through daily interactions with patients and customers. 
 
Reports 1 and 2 of the Evidence Base Review clearly demonstrate the potential for 
community pharmacists to improve the public’s health.  There has been increasing 
recognition of the contribution that they can make to improving the public’s health 
and the need to integrate them into the wider public health workforce. 
 
The new pharmacy global contracts and pharmacy public health strategy for 
England sets the framework for the current and future public health role of 
pharmacy.  We hope this role will develop further and that community 
pharmacists’ skills and knowledge will be harnessed even more effectively in order 
to improve the public’s health.  
 
The following report summarises the evidence base linked to national targets and 
makes recommendations for action. PCTs may wish to use the findings to develop 
pharmacy services to improve the health of communities that they serve and to 
meet local health improvement targets. 
 
 
Professor Jim McEwen 
Chair 
PharmacyHealthLink 
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What is pu blic health?  
 
Public health is the study and practice of how best to improve the overall health, 
and health gains, of populations rather than individuals.  The most widely used 
and over-arching definition of public health was coined by Sir Donald Acheson in 
1988 as: 
 
“the science and art of preventing disease, prolonging life and promoting, 
protecting and improving health through the organised efforts of society”. 
1 
 
This definition encompasses a very wide range of activities and emphasises the 
importance of a strategic approach to public health as well as collaboration 
between different groups and individuals to achieve their aims. 
 
Within this definition pharmacists can apply their pharmaceutical skills, knowledge 
and resources to promote these objectives with the aim of defining, addressing 
and monitoring the real health needs of the population. This application is 
sometimes referred to as ‘pharmaceutical public health’.2  
 
Three domains of  p u blic health3 
Health protection & 
prevention 
Health & social care  Health 
improvement  
• Disease and injury 
prevention 
• Communicable 
disease control 
• Environmental 
health  
• Emergency planning 
• Quality 
• Clinical effectiveness 
• Efficiency 
• Service planning 
• Audit and evaluation 
• Clinical governance 
• Employment 
• Housing 
• Family/community 
• Education 
• Inequalities/ 
exclusion 
• Lifestyles 
 
 
The pu blic health approach:3 
• emphasises the collective responsibility for improvement in health and on 
prevention of disease;  
• recognises the key role of the state, linked to a concern for the underlying 
socio-economic and wider determinants of health, as well as disease;  
• multidisciplinary, incorporating quantitative as well as qualitative methods; 
and  
• emphasises partnerships with all those who contribute to the health of the 
population.  
 
                                                 
1 Acheson D. (1988) Public Health in England. Report of the Committee of Inquiry into the Future Development of the Public 
Health Function. London: Department of Health, 1988. 
2 Walker, R. (2000) Pharmaceutical Public Health: The End of Pharmaceutical Care? The Pharmaceutical Journal. 264: 340. 
3 Faculty of Public Health. www.fph.org.uk  
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The 10 key areas of  p u blic health practice4 
 
The Faculty of Public Health identifies 10 core elements of public health practice, 
which form the basis of competency standards. These 10 core elements provide a 
useful starting point for illustrating various roles pharmacists could play at a 
population level. 
 
1. Surveillance and assessment of the population’s health and well-being.  
2. Promoting and protecting the population’s health and well-being. 
3. Developing quality and risk management within an evaluative culture. 
4. Collaborative working for health. 
5. Developing health programmes and services and reducing inequalities. 
6. Policy and strategy development and implementation. 
7. Working with and for communities. 
8. Strategic leadership for health. 
9. Research and development. 
10. Ethically managing self, people and resources. 
 
Community pharmacists need to be competent in all ten areas of public health 
practice to deliver the future public health agenda. Aligning the core pharmacy 
public health competencies to the ten areas of public health practice fits within the 
ethos of generic health worker competencies and would facilitate joint registration 
for pharmacists wanting to specialise in public health between the Royal 
Pharmaceutical Society of Great Britain and the Faculty of Public Health. 
 
The Report of the Chief Medical Officer’s Project to Strengthen the Public Health 
Function5 provides a framework for assessing the different contributions from 
different elements of the public health workforce. In particular the document 
refers to three broad categories: 
 
♦ P u blic health ‘contributors’  – people who do not have specific 
responsibility for carrying out health interventions but who do have an 
influence on health improvement and reducing inequalities through the nature 
of their jobs. In the case of pharmacy this could include, for example, pharmacy 
technicians and support staff. 
 
♦ P u blic health ‘practi tioners’ – people who spend a large proportion of 
their job engaging with and providing health interventions to individuals, 
groups and communities. This could include community, primary care and 
hospital pharmacists.  
 
♦ P u blic health ‘specialists’ – people who work at a strategic or senior 
management level and therefore may have a profound influence on the health 
and well-being of large numbers of people. For pharmacy this could include, 
                                                 
 
4 Department of Health (2001) The Report of the Chief Medical Officer’s Project to Strengthen the Public Health Function. 
www.doh.gov.uk/cmo/phfunction.htm  
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for example, pharmaceutical advisors working at a primary care or strategic 
level. 
 
 
Pharmacy p u blic health policy  context 
 
Community pharmacists already make a significant contribution to public health 
through their day-to-day activities. These include the provision of information and 
advice, facilitating self-care, the care and support of drug users, visits to the 
homes of housebound people and advice on smoking cessation and emergency 
hormonal contraception. Community pharmacy is in a unique position to deliver 
the pubic health agenda. Comprising around 12,000 dedicated premises,6 
pharmacists provide a highly accessible, informal network of ‘drop in’ access points 
for medicines and advice on health and well-being, making them a significant 
component of the public health workforce. 
 
Community pharmacy is unusual in that it straddles both public and private 
sectors.  Community pharmacists are independent contractors to the health service, 
giving advice and dispensing medicines for the NHS.  But they also have to survive 
as small businesses in local communities or as major retailers in the high street.  
The dual health and commercial role occupied by pharmacy offers a unique 
opportunity to target activities towards healthy people, as well as those with 
health problems.  Pharmacy users’ experiences are often more ‘consumer’ 
orientated than ‘patient’ orientated. 
 
The Government’s focus on public health is considerable and is primarily directed 
at developing the capacity within the public health workforce and reducing 
inequalities in health.7,8 Often the potential contribution that pharmacists can 
make to achieve these stated aims is omitted. However, in recent years, a number 
of key policy documents have outlined the areas in which the public health role of 
pharmacists should be developed further. For example, the Health Committee 
Inquiry into Public Health recommended that ‘the Government takes steps for 
community pharmacists to play a more active role in public health’. 9 The 
Government strategy document for outlining the future direction of pharmacy, 
Pharmacy in the Future, recognised that the skills and expertise of the pharmacist 
could be further utilised. 10 According to the strategy this could be achieved 
through pharmacy becoming more integrated with the NHS, through working more 
flexibly as part of a multidisciplinary healthcare team and through playing a 
                                                 
6 Royal Pharmaceutical Society of Great Britain. Statistics of pharmacists and registered premises. 
www.rpsgb.org.uk/pdfs/registerstats.pdf 
7 Department of Health (2002) Improvement, expansion and reform: the next 3 years.  Priorities and planning framework 2003 – 
2006. Department of Health: London. www.doh.gov.uk/planning2003-2006 
8 Department of Health (2001) Report of the Chief Medical Officer’s project to strengthen the public health function.  
Department of Health: London.  www.doh.gov.uk/phfunction.htm. AND  
Department of Health (2002) Tackling Health Inequalities: 2002 Cross-Cutting Review: Department of Health: London. 
www.doh.gov.uk/healthinequalities/ccsrfinal.pdf 
9 House of Commons Health Committee (2001). Second Report on Public Health. London: The Stationery Office. 
www.doh.gov.uk/phreport2.htm 
10 Department of Health (2000) Pharmacy in the Future – Implementing the NHS Plan. Department of Health: London. 
www.doh.gov.uk/pharmacyfuture  
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greater role in supporting self-care. Tackling Health Inequalities: A Programme for 
Action highlights the importance of community settings and services in addressing 
health inequalities, including community pharmacies.11 A Programme for Action 
goes on to state that community pharmacists have a vital role to play in improving 
the public’s health by giving advice, specifically on how to quit smoking, offering 
exercise on prescription, identifying patients at risk of heart disease and providing 
services for substance users.12  A Vision for Pharmacy in the New NHS, recognises 
the untapped contribution that pharmacists can make to the public health 
agenda.13  The Vision made a commitment to develop a pharmaceutical public 
health strategy for England by 2005, integrating pharmacy with the wider public 
health agenda and workforce. The Vision also reflected the public health 
contribution that community pharmacy makes in the new pharmacy contract.  The 
contract for community pharmacy in England is essential to delivering public health 
services in community pharmacy.  Under the new contractual framework, essential 
services, provided by all community pharmacies will include the promotion of 
healthy lifestyles and the promotion of self-care. The inclusion of public health in 
the essential service element recognises the importance of public health and the 
contribution that can be made by pharmacy. 
 
While the Department of Health for England provides overarching policies to tackle 
UK wide public health issues, Northern Ireland, Scotland and Wales have each 
developed their own set of priorities based on the particular needs of their 
regional communities.  
 
The Scottish Executive’s vision for improving the public’s health, is to reduce 
inequalities, social exclusion and poverty. Reducing the differences in opportunity 
and experience is at the heart of work to improve Scotland’s health, as is the belief 
that improving living and working conditions, and influencing lifestyle, will lead to 
better health. All parts of the Scottish NHS are expected to contribute to this 
agenda by working together in the community to improve health and reduce health 
inequalities.14 Pharmacy for Health: The Way Forward for Pharmaceutical Public 
Health in Scotland, recognises the often untapped potential contribution which 
pharmacy can make to improving the public’s health and the need to engage all 
pharmacists in the public health agenda, utilising their skills and experiences to 
the full.15 
 
The National Assembly for Wales has as its set of guiding principles, ‘act now for 
the future’, ‘reduce poverty and achieve equality’. The aim is to improve the 
health and well-being of people in Wales and to reduce inequalities in health. 
                                                 
11 Department of Health (2003) Tackling Health Inequalities: A Programme for Action. Department of Health: London. 
www.doh.gov.uk/healthinequalities/programmeforaction  
12 Department of Health (2003) Tackling inequalities: A Programme for Action.  Department of Health: London. 
www.doh.gov.uk/healthinequalities/programmeforaction/index.htm  
13 Department of Health (2003) A Vision for Pharmacy in the New NHS. Department of Health: London. 
www.doh.gov.uk/pharmacyvision/visionforpharmacy.pdf  
14 The Scottish Office (1999) Towards a Healthier Scotland – A White Paper on Health. The Stationery Office: Scotland. 
www.scotland.gov.uk/library/documents-w7/tahs-00.htm  
15 NHS Scotland (2002) Pharmacy for Health: The Way Forward for Pharmaceutical Public Health in Scotland. Public Health 
Institute of Scotland: Glasgow. www.phis.org.uk  
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Improving quality and effectiveness of healthcare and promoting interagency 
working, underpins this strategy.16 
 
In Northern Ireland there is a multidisciplinary approach, that recognises that 
social, economic, physical, cultural and environmental factors largely determine 
health and well being. The strategy is to take action to tackle the factors that 
adversely affect health and increase health inequalities.17 Making it Better - A 
Strategy for Pharmacy in the Community recognises that pharmacy plays an 
important role within the health services and community as a whole due to the 
accessibility of pharmacy, and therefore in a prime position to deliver services that 
improve the public’s health. The strategy aims to build on traditional roles within 
pharmacy, to use pharmacists’ skills to the fullest and make pharmacy an integral 
part of the health and social care team.18 
 
Overall, the message is clear throughout Great Britain: pharmacy makes an 
important contribution to improving the public’s health and reducing health 
inequalities, due to the skills and experience of the pharmacy workforce and 
location and accessibility of pharmacies.  All four countries are now recognising this 
untapped resource and the need to engage all pharmacists in the public health 
agenda.  In the future, pharmacists will become more recognised as public health 
practitioners, utilising their skills and experiences to the full and becoming more 
integrated with the NHS and wider public health workforce. 
 
Our Reports 1 and 2 of the Evidence Base Review clearly demonstrated the 
potential of community pharmacists to improve the public’s health.  The diagram 
below represents pictorially the evidence summary of where community pharmacy 
contributes to improving the public’s health.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                 
16 Government of the National Assembly for Wales (2001) Plan for Wales 2001. Government of the National Assembly for 
Wales. www.planforwales.wales.gov.uk  
17 Department of Health, Social Services and Public Policy (2002) Investing for Health. Department of Health, Social Services 
and Public Policy: Belfast. www.investingforhealthni.gov.uk  
18 Department of Health, Social Services and Public Policy (2003) Making it Better: A Strategy for Pharmacy in the Community. 
Department of Health, Social Services and Public Policy: Belfast. www.dhsspsni.gov.uk/publications/2003/makingitbetter.pdf  
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Diagram 1 Evidence summary of  where community  pharmacy   
contributes to improving the pu bl ic’s health 
 
Coronary Heart Disease** 
Diabetes*** 
  Hypertension* 
 Smoking Cessation*** 
 Weight Management** 
 Breastfeeding*  Falls* 
Immunisation* Folic Acid Promotion**  Flu immunisation*** 
 Emergency Contraception***   
 Sexual Health*   
 Drugs Use*   
 
Early years               Teenage                     Adulthood                         Older age 
 
***  Strong Evidence 
** Evidence 
* Some evidence but further research is needed 
 
This report draws together the key findings from Reports 1 and 2, summarising the 
evidence, linking it to the national targets of the four home countries and making 
recommendations for action.  The evidence summaries are broken down into three 
sections. The evidence relating to health topics, factors affecting the effectiveness 
of interventions and developing relationships with stakeholders.  
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1 Evidence summaries – Where community pharmacy can be 
ef fective in improving the pu blic’s health 
 
1.1 Health Improvement:  Indiv id uals 
 
Cancer and Coronary  Heart  D isease (CHD) 
 
Cancer is a major cause of morbidity in the United Kingdom. There are more than 
200 different types of cancer, but four of them: breast, lung, large bowel and 
prostate, account for over half of all new cancer cases.19  
 
Coronary heart disease (CHD) is also a major cause of morbidity in the UK.  More 
than 1.4 million people suffer from angina, 300,000 have heart attacks every year 
and more than 110,000 die of heart problems in England every year.20 
 
There is considerable overlap between the risk factors for cancer and coronary 
heart disease such as, smoking, poor nutrition, obesity, and physical inactivity. The 
following section summarises these risk factors and the evidence on the 
contribution pharmacy can make to reduce these.  There is a significant correlation 
between socio-economic status and vulnerability to both cancer and CHD. Among 
unskilled men the death rate from CHD is almost three times higher than it is 
among professionals and these differences have more than doubled in the past 
twenty years. 21 There are real inequalities in terms of who gets cancer. People 
from deprived or less affluent backgrounds are more likely to get some types of 
cancer, and overall more likely to die from it once they are diagnosed. In the early 
1990s lung cancer among men was nearly five times higher among unskilled 
workers than among professional groups.22 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                 
19 Cancer Research UK (2003) CancerStats: Incidence – UK. Cancer Research UK: London. www.cancerresearchuk.org  
20 Department of Health (2000) National Service Framework for Coronary Heart Disease. Department of Health: London. 
www.doh.gov.uk/nsf/coronary.htm  
21 Department of Health (2000) National Service Framework for Coronary Heart Disease. Department of Health: London.  
www.doh.gov.uk/nsf/coronary.htm 
22 Health Development Agency (2002) Cancer prevention: A resource to support local action in delivering the NHS Cancer 
Plan.  Health Development Agency: London. www.hda-online.org.uk/html/resources/cancer_prevention 
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Coronary Heart  Disease targets: 
• Reduce substantially the mortality rates from heart disease by at least 40% in 
people under 75 by 2010. (England)23 
• Contribute to a national reduction in death rates from CHD of at least 25% in 
people under 75 by 2005 compared to 1995-1997, targeting the 20% of areas 
with the highest rates of CHD. (England)24 
• Update GP practice-based registers so patients with CHD and diabetes 
continue to receive appropriate advice and treatment in line with NSF 
standards. (England)25 
• Improve the management of patients with heart failure in line with the NICE 
Clinical Guidelines. (England)26 
• Reduce age standardised mortality rate from CHD in people under 75 years by 
50% between 1995 and 2010 (Scotland)27 
• Bring five year survival-rates for serious cardiac disease closer to the best in 
Europe by 2010. (Wales)28 
 
Cancer targets: 
• Reduce substantially the mortality rates from cancer by at least 20% in people 
under 75 by 2010. (England)29 
• Contribute to a national reduction in cancer death rates of at least 12% in 
people under 75 by 2005 compared to 1995-7, targeting the 20% of areas with 
the highest rates of cancer.(England)30 
• Reduce age standardised mortality rate from all cancers in people under 75 
years by 20% between 1995 and 2010.(Scotland)31 
• Bring five year survival-rates for cancers far closer to the best in Europe by 
2010.(Wales)32 
 
 
 
 
 
 
 
                                                 
23 Department of Health (2002) Improvement, expansion and reform: the next 3 years.  Priorities and planning 
framework 2003 – 2006. Department of Health: London. www.doh.gov.uk/planning2003-2006 
24 Department of Health (2002) Improvement, expansion and reform: the next 3 years.  Priorities and planning framework 2003 – 
2006. Department of Health: London. www.doh.gov.uk/planning2003-2006 
25 Department of Health (2002) Improvement, expansion and reform: the next 3 years.  Priorities and planning framework 2003 – 
2006. Department of Health: London. www.doh.gov.uk/planning2003-2006 
26 Department of Health (2002) Improvement, expansion and reform: the next 3 years.  Priorities and planning framework 2003 – 
2006. Department of Health: London. www.doh.gov.uk/planning2003-2006 
27 The Scottish Office (1999) Towards a Healthier Scotland – A White Paper on Health. The Stationery Office: Scotland. 
www.scotland.gov.uk  
28 The Government of the National Assembly for Wales (2001) Plan For Wales 2001. www.planforwales.wales.gov.uk 
29 Department of Health (2002) Improvement, expansion and reform: the next 3 years.  Priorities and planning 
framework 2003 – 2006. Department of Health: London. www.doh.gov.uk/planning2003-2006 
30 Department of Health (2002) Improvement, expansion and reform: the next 3 years.  Priorities and planning framework 2003 – 
2006. Department of Health: London. www.doh.gov.uk/planning2003-2006 
31 The Scottish Office (1999) Towards a Healthier Scotland – A White Paper on Health. The Stationery Office: Scotland. 
www.scotland.gov.uk 
32 The Government of the National Assembly for Wales (2001) Plan For Wales 2001. www.planforwales.wales.gov.uk  
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Primary prevention of  Cancer and Coronary Heart  Disease  
 
 
Smoking  
 
Smoking causes one in seven deaths from heart disease and among those aged 
under 65 years, smoking causes two in five deaths from stroke.33 Passive smoking 
is also a major cause of morbidity and mortality, contributing to death from heart 
disease and a range of other problems.34 
 
Smoking causes one in three cancer deaths in the UK, 84% of these deaths are 
from lung cancer.35 Smoking is also a major cause of cancer of the mouth, 
oesophagus, bladder, kidney and pancreas.36  
 
Smoking is responsible for the major part of mortality differences in social class in 
middle age.  Among men aged 35-69, it is estimated that if smoking rates among 
social class V were the same as those in social class I, health inequity would reduce 
by half.37, 38 
 
 
Smoking in pregnancy 
 
Smoking in pregnancy is associated with many foetal and neo-natal problems such 
as low birth-weight, pre-term delivery, placental damage, miscarriage and sudden 
infant death syndrome.  It can also be the cause of respiratory problems such as 
chest infections and can aggravate asthma in young children.39  If smoking in 
pregnancy fell by just 10%, it is estimated that the average infant birth-weight 
would rise to just over 3.5grams and if no one smoked during pregnancy the 
average birth-weight would rise by an estimated 36 grams.40  Low birth weight is 
associated with increased mortality and morbidity in the first year of life, and 
throughout childhood.41   Smoking in pregnancy is linked to health inequalities; 
smoking in pregnancy is four times more prevalent among women in social class V 
than those in social class I.  Teenage mothers are most likely of all age groups to 
smoke in pregnancy.42 
                                                 
33 Callum, C. (1998) The UK smoking epidemic: deaths in 1995. Health Development Agency: London. 
34 Royal College of Physicians (1992) Smoking and the young.  London: Royal Collage of Physicians. 
35 Callum, C. (1998) The UK smoking epidemic: deaths in 1995. Health Development Agency: London. 
36 US Department of Health and Human Services (2001) Women and smoking: a report of the Surgeon General. US Department 
of Health and Human Services: Rockville, USA.  
37 Jarvis, M., Wardle, J. (1999) Social patterning of individual health behaviours: the case of cigarette smoking.  In Marmot, M., 
Wilkinson, R. (eds) Social determinants of health.  Oxford University Press: Oxford. 
38 Department of Health (2002) Tackling Health Inequalities: 2002 Cross Cutting Review.  Department of Health: London. 
www.doh.gov.uk/healthinequalities/ccsrsummaryreport.htm  
39 Health Development Agency (1999) Smoking and pregnancy: A survey of knowledge, attitudes and behaviour 1992-1999.  
Health Development Agency: London. 
40 Department of Health (2002) Tackling Health Inequalities: 2002 Cross Cutting Review.  Department of Health: London. 
www.doh.gov.uk/healthinequalities/ccsrsummaryreport.htm  
41 Department of Health (2002) Tackling health inequalities: 2002 cross-cutting review.  Department of Health: London.  
www.doh.gov.uk/healthinequalities/ccsrsummaryreport  
42 Department of Health (2002) Tackling Health Inequalities: 2002 Cross Cutting Review.  Department of Health: London. 
www.doh.gov.uk/healthinequalities/ccsrsummaryreport.htm  
 16 
Smoking targets:   
• Reduce adult smoking in all social classes so that the overall rate falls from 
28% to 24% or less by the year 2010; with a fall to 26% by the year 2005. 
(England and Wales)43 
• Reduce smoking among children from 13% to 9% or less by the year 2010; with 
a fall to 11% by the year 2005. (England and Wales)44 
• Reduce the percentage of women who smoke during pregnancy from 23% to 
15% by the year 2010; with a fall to 18% by the year 2005. (England and 
Wales)45 
• Reduce the rate of smoking, contributing to the national target of reducing the 
rate in manual groups from 32% in 1998 to 26% by 2010. (England)46  
• Ensure 800,000 smokers from all groups successfully quit at the 4 week stage 
by 2006. (England)47 
• Deliver a 1% reduction per year in the proportion of women continuing to 
smoke throughout pregnancy, focussing especially on smokers from 
disadvantaged groups as a contribution to the national target to reduce by at 
least 10% the gap in mortality between ‘routine’ and ‘manual’ groups and the 
population as a whole by 2010, starting with children under 1 year. (England)48 
• Reduce rate of smoking among adults (16-64) from an average of 35% to 33% 
between 1995 and 2005 and to an average of 31% by 2010.(Scotland)49 
• Reduce smoking among young people (12-15 year olds) from 14% to 12% 
between 1995 and 2005 and to 11% by 2010.(Scotland)50 
• Reduce the proportion of women who smoke during pregnancy from 29% to 
23% between 1995 and 2005 and to 20% by 2010.(Scotland)51 
• Increase the proportion of 11-16 year old children who do not smoke from 86.5% 
in 2000 to 89% by 2006.  (Northern Ireland)52 
• Increase the proportion of pregnant women who do not smoke from 78% in 
2000 to 82% in 2005. (Northern Ireland)53 
• Increase the proportion of adults who do not smoke from 73% in 2000/01 to 
75% in 2006/07. (Northern Ireland)54 
                                                 
43 Department of Health (1998) Smoking Kills.  White paper on tobacco.  The Stationery Office: London. www.archive.official-
documents.co.uk/document/cm41/4177/4177.htm  
44 Department of Health (1998) Smoking Kills.  White paper on tobacco.  The Stationery Office: London. www.archive.official-
documents.co.uk/document/cm41/4177/4177.htm  
45 Department of Health (1998) Smoking Kills.  White paper on tobacco.  The Stationery Office: London. www.archive.official-
documents.co.uk/document/cm41/4177/4177.htm  
46 Department of Health (2002) Improvement, expansion and reform: the next 3 years.  Priorities and planning framework 2003 – 
2006. Department of Health: London. www.doh.gov.uk/planning2003-2006 
47 Department of Health (2002) Improvement, expansion and reform: the next 3 years.  Priorities and planning framework 2003 – 
2006. Department of Health: London. www.doh.gov.uk/planning2003-2006 
48 Department of Health (2002) Improvement, expansion and reform: the next 3 years.  Priorities and planning framework 2003 – 
2006. Department of Health: London. www.doh.gov.uk/planning2003-2006 
49 The Scottish Office (1999) Towards a Healthier Scotland – A White Paper on Health. The Stationery Office: Scotland. 
www.scotland.gov.uk 
50 The Scottish Office (1999) Towards a Healthier Scotland – A White Paper on Health. The Stationery Office: Scotland. 
www.scotland.gov.uk 
51 The Scottish Office (1999) Towards a Healthier Scotland – A White Paper on Health. The Stationery Office: Scotland. 
www.scotland.gov.uk 
52 Department of Health, Social Services and Public Safety (2002) Investing for Health. A five year tobacco action plan: 
consultation document.DHSSPS www.dhsspsni.gov.uk/publications/2002/tobacco_plan.pdf 
53 Department of Health, Social Services and Public Safety (2002) Investing for Health. A five year tobacco action plan: 
consultation document.DHSSPS www.dhsspsni.gov.uk/publications/2002/tobacco_plan.pdf 
54 Department of Health, Social Services and Public Safety (2002) Investing for Health. A five year tobacco action plan: 
consultation document.DHSSPS www.dhsspsni.gov.uk/publications/2002/tobacco_plan.pdf 
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• Increase the proportion of non-smokers in manual groups from 65% in 2000/01 
to 69% in 2006/07. (Northern Ireland)55 
 
 
Where community  pharmacy can be ef fective 
 
Community pharmacy can contribute to reducing the number of people who smoke 
by providing stop smoking services.  The Evidence Base Review found that 
providing community based stop smoking services, run by trained pharmacy staff 
is effective and cost-effective.  Training, especially in behaviour change methods, 
was found to be essential to the success of pharmacy stop smoking services. 
Without training pharmacists are more likely just to respond to smokers’ requests 
for advice rather than to proactively initiate conversations about smoking.   
 
Recommendations: 
• Establish appropriate infrastructure support to enable pharmacy to contribute 
effectively in co-operation with other health professionals and related services. 
• National and local health commissioners must include community pharmacies 
as providers of stop smoking services. 
• Stop smoking training for pharmacists must be established, particularly for 
behaviour change methods. 
 
 
Healthy eating, obesity  and weight red uction 
 
Diet plays a fundamental role in the development of heart disease, cancer, obesity 
and type 2 diabetes. Both the type and amount of fat consumed and its 
relationship to blood cholesterol, along with salt intake linked to blood pressure, 
affect the development of CHD.56 An increased intake of fruit and vegetables has 
been identified as an important factor in reducing the rate of both heart disease 
and some cancers.57 
 
The number of people who are overweight and obese in the UK has increased in 
recent years.  45% of men and 33% of women are overweight and 17% of men and 
20% of women are obese.  The number of men who are obese has increased by 
50% in 10 years, and the number of women who are obese has increased by 42% in 
10 years.58  The prevalence increases with age and is greatest among those of low 
socio-economic status, particularly in women, 25% of women from unskilled 
occupations are obese compared with 14% of women in professional jobs.59   The 
                                                 
55 Department of Health, Social Services and Public Safety (2002) Investing for Health. A five year tobacco action plan: 
consultation document.DHSSPS www.dhsspsni.gov.uk/publications/2002/tobacco_plan.pdf 
56 The Health Development Agency (2001) Coronary Heart Disease: Guidance for implementing the preventive aspects of the 
National Service Framework.  The Health Development Agency: London. 
www.hdaonline.org.uk/downloads/pdfs/chdframework.pdf 
57 The Health Development Agency (2001) Coronary Heart Disease: Guidance for implementing the preventive aspects of the 
National Service Framework.  The Health Development Agency: London. 
www.hdaonline.org.uk/downloads/pdfs/chdframework.pdf 
58 Petersen, S. Mockford, C. and Rayner, M. (1999) Coronary heart disease statistics.  British Heart Foundation: London. 
59 Petersen, S. Mockford, C. and Rayner, M. (1999) Coronary heart disease statistics.  British Heart Foundation: London. 
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prevalence also increases within certain ethnic minorities, particularly people of 
Asian and Afro-Caribbean origin.60  The prevalence of obesity is also increasing in 
children.  People are at considerably increased risk of obesity in adulthood if they 
are either from a manual background, were overweight in childhood and/or their 
parents are overweight or obese.61 Obesity is known to increase the risk of heart 
disease62 and cancer of the endometrium, kidney and colon, and probably 
increases the risk of post-menopausal breast cancer.63  
 
Healthy eating targets:   
• Increase the daily consumption of fruit and vegetables, particularly among 
those on low incomes, to five portions. (England)64 
• Double the average consumption of fruit and vegetables. Increase by half the 
intake of bread (mainly wholemeal and brown breads). Double the daily intake 
of breakfast cereals.  Reduce the proportion of total fat and of saturated fat by 
over 5%. Reduce average salt intake by over a third. Halve child intake of non-
milk sugar; increase the intake of non-sugar carbohydrates by a quarter. 
Double the consumption of oily fish. (Scotland)65 
 
Obesity  and weight reduction targets:   
• Stop the increase in levels of obesity in men and women so that by 2010, the 
proportion of men who are obese is less than 17% and of women is less than 
20%. (Northern Ireland)66 
 
 
Where community  pharmacy can be ef fective 
 
Community pharmacy can contribute to reducing the number of people who are 
obese and overweight by running pharmacy-based weight reduction programmes 
and promoting healthy eating and physical activity. Pharmacies, both in the UK 
and internationally, have initiated weight-loss programmes, and there are also 
examples of pharmacy weight monitoring programmes as part of heart disease risk 
factor identification programmes. Further research into the potential contribution 
of pharmacy to weight reduction is urgently needed with a view to extending and 
expanding successful programmes in the future. 
 
 
 
 
                                                 
60 Health Development Agency (2002) Cancer prevention: A resource to support local action in delivering the NHS Cancer 
Plan.  Health Development Agency: London. www.hda-online.org.uk/html/resources/cancer_prevention  
61 Petersen, S. Mockford, C. and Rayner, M. (1999) Coronary heart disease statistics.  British Heart Foundation: London. 
62 Department of Health (2000) The NHS Cancer Plan: A plan for investment a plan for reform. Department of Health: London. 
www.doh.gov.uk/cancer/cancerplan.htm 
63 World Cancer Research Fund (1997) Food, nutrition and the prevention of cancer: a global perspective.  www.wcrf.org.uk  
64 Department of Health (2000) The NHS Plan: A plan for investment a plan for reform.  The Stationery Office: London. 
www.nhs.uk/nationalplan  
65 Scottish Executive (2001) Cancer in Scotland: Action for Change. www.scotland.gov.uk/library3/health/csac-06.asp 
66 Department of Health, Social Services and Public Safety (2002) Investing for Health.  DHSSPS: Belfast  
www.dhsspsni.gov.uk/publications/2002/invest1.pdf  
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Recommendations: 
• Research and evaluate the potential contribution of pharmacy to promoting 
healthy eating and weight reduction. 
• Establish appropriate infrastructure support to enable pharmacy to contribute 
effectively in co-operation with other health professionals and related services.  
 
 
Physical activi ty  
 
There is an international consensus that having a physically active lifestyle is 
important for health and has great potential for health gain.67 Physical inactivity 
can contribute to the development of cancer and heart disease, and also have an 
impact on diabetes, mental health and osteoporosis.68 The Department of Health’s 
recommendation for adults is at least 30 minutes of physical activity on five or 
more days of the week.  However, six out of ten men and seven out of ten women 
in England are not active enough to benefit their health.69 
 
Physical activi ty  targets: 
• 50% of all adults aged over 16 and 80% of all children aged 16 and under to 
meet the minimum recommended levels of physical activity by 
2022.(Scotland)70 
• Increase proportion of 11-15 year olds taking vigorous exercise 4 times or more 
weekly from 32% in 1994 to 40% in 2005 and to 50% in 2010. (Scotland)71 
• 50% of men and 40% of women (aged 16-64) to be taking 30 minutes of 
moderate activity on 5 or more occasions each week by 2005 and 60% and 
50%, respectively, by 2010.(Scotland)72 
 
 
Where community  pharmacy can be ef fective 
 
The Evidence Base Review did not find any individual studies where pharmacy can 
contribute to physical activity.  Further research is needed to determine where 
pharmacy can contribute to promoting physical activity. 
 
 
 
 
 
                                                 
67 World Health Organisation (1995) Exercise for Health: WHO/FIMS committee on physical activity for health.  Bulletin of the 
World Health Organisation.  73 (2): 135-6. 
68 Health Development Agency (2002) Cancer prevention: A resource to support local action in delivering the NHS Cancer 
Plan.  Health Development Agency: London. See www.nice.org.uk 
69  See www.nice.org.uk 
70 Scottish Executive (2002) A strategy for physical activity - a consultation: Physical Activity Task 
Force.www.scotland.gov.uk/consultations/health/patf2-03.asp  
71 The Scottish Office (1999) Towards a Healthier Scotland – A White Paper on Health. The Stationery Office: Scotland. 
www.scotland.gov.uk 
72 The Scottish Office (1999) Towards a Healthier Scotland – A White Paper on Health. The Stationery Office: Scotland. 
www.scotland.gov.uk 
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Recommendations: 
• Research the potential contribution of pharmacy to promote physical activity.  
• Establish appropriate infrastructure support to enable pharmacy to contribute 
effectively in co-operation with other health professionals and related services. 
 
 
Alcohol  
 
In the UK 92% of men and 86% of women drink alcohol with drinking playing a 
mostly enjoyable part in UK culture. But for some people the misuse of alcohol 
brings serious consequences for the drinkers themselves, for their families and 
friends, and for the community as a whole.73 Current estimates suggest 28,000 to 
33,000 deaths a year are alcohol-related, due to accidents, injury and direct health 
effects on the body. Too much alcohol can affect the liver, digestive system, brain, 
nervous system, heart and circulatory system, bones, skin, muscles and sex organs. 
It also has an impact on nutrition, the development of some types of cancer and in 
pregnant women, the development of the foetus.74 
 
Alcohol targets: 
• Reduce incidence of adults exceeding weekly limits of 21(men) and 14 units 
(women) of alcohol: from 33% to 31% for men between 1995 and 2005 and to 
29% by 2010. From 13% to 12% for women between 1995 and 2005 and to 11% 
by 2010. (Scotland)75 
• Reduce frequency and level of drinking from 20% of 12-15 year olds to 18% 
between 1995 and 2005 and to 16% by 2010. (Scotland)76 
 
 
Where community  pharmacy can be ef fective 
 
Although a highly sensitive topic, research found that pharmacy has the potential 
to offer support and advice on alcohol consumption.  However, common barriers to 
receiving information on sensitive topics, especially privacy, confidentiality and 
training, need to be addressed. 
 
 
 
 
 
 
 
                                                 
73 Department of Health (2002) National Alcohol Harm Reduction Strategy: Consultation Document.  Department of Health: 
London www.doh.gov.uk/alcohol/pdf/alcoholharm.doc  
74 www.alcoholconcern.org.uk  
75 The Scottish Office (1999) Towards a Healthier Scotland – A White Paper on Health. The Stationery Office: Scotland. 
www.scotland.gov.uk 
76 The Scottish Office (1999) Towards a Healthier Scotland – A White Paper on Health. The Stationery Office: Scotland. 
www.scotland.gov.uk 
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Recommendations: 
• Barriers to receiving information on sensitive topics, especially privacy, 
confidentiality and training must be addressed. 
• Research into where pharmacy can contribute to improving the public’s health 
in regard to alcohol consumption. 
• Establish appropriate infrastructure support to enable pharmacy to contribute 
effectively in co-operation with other health professionals and related services. 
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Secondary prevention of  Coronary Heart Disease -  screening and 
management  
 
People who have symptoms of heart disease, stroke, transient ischaemic attack 
(TIA), peripheral vascular disease (PVD), or multiple risk factors for heart disease, 
are typically three to five times more likely to die, suffer a heart attack or other 
major cardiovascular event, than people without such conditions or risk factors.   
There are simple treatments and important lifestyle changes that can reduce 
people’s risks substantially and that slow and perhaps even reverse progression of 
coronary heart disease. When used appropriately, these interventions can be more 
cost-effective than many other treatments currently provided by the NHS.77  
 
The interventions that patients at high risk of coronary heart disease should 
receive, unless contraindicated, are:  
• advice about how to stop smoking including advice on the use of nicotine 
replacement therapy;  
• information about other modifiable risk factors and personalised advice about 
how they can be reduced (including advice about physical activity, diet, 
alcohol consumption, weight and diabetes); 
• advice and treatment to maintain blood pressure below 140/85 mm Hg;  
• low dose aspirin (75 mg daily);  
• statins and dietary advice to lower serum cholesterol;  
• ACE inhibitors for people who also have left ventricular dysfunction;  
• beta-blockers for people who also have had a myocardial infarction;  
• warfarin or aspirin for people over 60 years old who also have atrial fibrillation; 
and  
• meticulous control of blood pressure and glucose in people who also have 
diabetes.78 
 
 
 
 
 
 
 
 
 
 
 
 
  
                                                 
77 Department of Health (2000) Coronary Heart Disease National Service Framework.  Department of Health: London. 
www.doh.gov.uk/pdfs/chdnsf.pdf  
78 Department of Health (2000) Coronary Heart Disease National Service Framework.  Department of Health: London. 
www.doh.gov.uk/pdfs/chdnsf.pdf 
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Coronary Heart  Disease Targets:   
• Improve the management of patients with heart failure in line with the NICE 
Clinical Guidelines. (England)79 
• Reduce substantially the mortality rates from heart disease by at least 40% in 
people under 75 by 2010. (England)80 
• Contribute to a national reduction in death rates from CHD of at least 25% in 
people under 75 by 2005 compared to 1995-1997, targeting the 20% of areas 
with the highest rates of CHD. (England)81 
• Reduce age standardised mortality rate from CHD in people under 75 years by 
50% between 1995 and 2010. (Scotland)82 
• Bring five-year survival-rates for serious cardiac disease closer to the best in 
Europe by 2010. (Wales)83 
 
 
Where community  pharmacy can be ef fective 
 
The Evidence Base Review found that community pharmacists are effective in 
providing secondary prevention for heart disease. Using pharmacy medication 
records to identify patients ‘at risk’ of heart disease was found to be an effective 
method of identifying and targeting health promotion measures, such as advice 
about how to stop smoking, physical activity, diet, alcohol consumption, weight 
and diabetes.  Pharmacists can also provide advice and information on maintaining 
a healthy blood pressure, and taking aspirin, statins, ACE inhibitors, beta-blockers 
and Warfarin. Pharmacy is a valuable source of advice on the appropriate use of 
prophylactic aspirin in the treatment of heart disease, and interventions to 
minimise potential harm from self-initiated aspirin treatment in people with contra-
indications to its use.  Pharmacists can also use dispensing information to identify 
and successfully manage lipid levels. A set of programmes based on these findings 
should be piloted as soon as possible in the UK, with appropriate infrastructure 
support and in co-operation with other health professionals and related services. 
 
 
 
 
 
 
 
 
 
                                                 
79 Department of Health (2002) Improvement, expansion and reform: the next 3 years.  Priorities and planning framework 2003 – 
2006. Department of Health: London. www.doh.gov.uk/planning2003-2006 
80 Department of Health (2002) Improvement, expansion and reform: the next 3 years.  Priorities and planning 
framework 2003 – 2006. Department of Health: London. www.doh.gov.uk/planning2003-2006 
81 Department of Health (2002) Improvement, expansion and reform: the next 3 years.  Priorities and planning framework 2003 – 
2006. Department of Health: London. www.doh.gov.uk/planning2003-2006 
82 The Scottish Office (1999) Towards a Healthier Scotland – A White Paper on Health. The Stationery Office: Scotland. 
www.scotland.gov.uk  
83 The Government of the National Assembly for Wales (2001) Plan For Wales 2001. www.planforwales.wales.gov.uk 
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Recommendations: 
• Further research and piloting of community pharmacy-based lipid management 
programmes and pharmacy based prophylactic aspirin treatment and 
monitoring programmes should commence as soon as possible in the UK. 
• The use of pharmacy medication records and dispensing data to target patients 
with risk factors for coronary heart disease in order to instigate health 
promotion measures, provide information, advice and referral. 
• Establish appropriate infrastructure support to enable pharmacy to contribute 
effectively in co-operation with other health professionals and related services. 
• Primary care organisations should be aware of how community pharmacy-
based services might be integrated into local service provision as a means of 
reducing rates of heart disease. 
 
 
Skin cancer  
 
Skin cancer is now the most common form of cancer in the UK. The number of cases 
in the UK has doubled in just 20 years. Skin cancer is mainly caused by excessive 
exposure to the sun. 57,700 people in the UK are diagnosed with it each year and 
in the last five years 8,000 people have died from it.84  
 
Where community  pharmacy can be ef fective 
 
Pharmacists can be a valuable source of information about sun protection because 
many sell a range of related products. Pharmacy-based information on skin cancer 
prevention raises awareness, but more research is needed to see whether this 
heightened awareness has a positive effect on behaviour patterns. 
 
Recommendations: 
• Expand the health promotion role of pharmacists in regard to sun protection 
and establish appropriate infrastructure support to enable pharmacy to 
contribute effectively in co-operation with other health professionals and 
related services. 
• Research the effectiveness of skin cancer health promotion through pharmacy 
in changing behaviour. 
 
 
Oral health 
 
Dental disease (tooth decay and gum disease) has decreased in the last 20 years 
in the UK, but is still linked to economic deprivation and social exclusion.85  Its 
peak occurs during childhood, affecting 38.3% of five-year olds in England, 51.6% 
in Wales and 54.9% in Scotland.  It causes progressive destruction of the crowns 
and teeth, accompanied with pain and infection.  50% of older people will have 
                                                 
84 www.doh.gov.uk/sunsafe  
85 Department of Health (2000) Modernising NHS Dentistry – implementing the NHS Plan.  Department of Health: London. 
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lost one or more teeth and 10% will have lost the majority of their teeth due to gum 
disease.  While tooth and gum disease are the major causes of tooth loss, dental 
erosion by acidic drinks and other sources of acid now effects 50% of children.  
Oral cancer is not uncommon in the UK and many cases are tobacco related; all 
cases can benefit from early diagnosis.  Dental disease can be reduced by 
behaviour change, which requires education and motivation, and is influenced by 
social and economic pressures.  These factors may account for the persistence of 
high levels of dental disease in economically deprived communities in the UK 
compared to more affluent areas where low levels are often found.86 
 
Oral health targets: 
• Anyone will be able to find a NHS Dentist simply by calling NHS Direct by 
2001.(England)87 
• By 2005, children aged 12 to have (on average) no more than 1.5 teeth decayed, 
missing or filled. (Scotland)88  
• By 2008, 90% of 18 year olds to have all their own teeth. (Scotland)89  
• By 2008, at least 80% of dentate adults aged 35-44 to have at least 21 or more 
teeth. (Scotland)90  
• Less than 5% of 45- 54 year olds to have no natural teeth by 2010. (Scotland)91 
• 60% of 5 year olds to have no experience of dental disease by 2010. 
(Scotland)92 
• By 2010 increase the levels of 5 year old children with no dental decay 
experience to 55% and to reduce the gap between the best and worst 
decayed/missing/filled scores by 20%. (Northern Ireland)93 
 
 
Where community  pharmacy can be ef fective 
 
Research shows that pharmacists could carry out a valuable role in oral health and 
are often asked by users to give advice and information on oral health.  Training in 
oral health promotion was found to increase the likelihood and effectiveness of 
pharmacists giving advice and information.  However, opportunities for 
pharmacists to recommend sugar-free medicines for children are limited as most 
requests from customers are for a named medicine. This places the pharmacist in a 
position of conflict between the roles of health professional and retailer. 
 
 
                                                 
86 Health Development Agency (2001) The scientific basis of dental health education: A policy document (revised fourth edition).  
Health Development Agency: London. 
87 Department of Health (2000) The NHS Plan: a plan for investment, a plan for reform.  Department of Health: London. 
www.nhs.uk/nationalplan  
88 The Scottish Office Oral Health Strategy for Scotland. www.scotland.gov.uk/library/documents/oral00.htm  
89 The Scottish Office Oral Health Strategy for Scotland. www.scotland.gov.uk/library/documents/oral00.htm 
90 The Scottish Office Oral Health Strategy for Scotland. www.scotland.gov.uk/library/documents/oral00.htm 
91 The Scottish Office (1999) Towards a Healthier Scotland – A White Paper on Health. The Stationery Office: Scotland. 
www.scotland.gov.uk 
92 The Scottish Office (1999) Towards a Healthier Scotland – A White Paper on Health. The Stationery Office: Scotland. 
www.scotland.gov.uk 
93 Department of Health, Social Services and Public Safety (2002) Investing for Health.  DHSSPS: Belfast  
www.dhsspsni.gov.uk/publications/2002/invest1.pdf 
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Recommendations: 
• Expand oral health promotion through pharmacy and establish appropriate 
infrastructure support to enable pharmacy to contribute effectively in co-
operation with other health professionals and related services.  
 
 
D iabetes 
 
Diabetes is becoming more common; around 1.3 million people are currently 
diagnosed with diabetes.  There are two main types of diabetes: Type 1 and Type 
2 diabetes. Type 1 diabetes develops most frequently in children and young 
adults, and is increasing in under fives. Type 2 diabetes is most commonly 
diagnosed in adults over the age of 40, although increasingly it is appearing in 
young people and young adults and many hundreds of thousands of people may 
have Type 2 diabetes without knowing it. 
 
People with diabetes, particularly Type 2 diabetes, are at significantly increased 
risk of developing coronary heart disease (CHD). The death rate for CHD is five 
times higher for people with diabetes.94 A number of other conditions also occur 
more commonly in people with diabetes, including, cataracts, infections of the 
urinary tract and skin, soft tissue conditions, skin conditions, depression, eating 
disorders and other mental health problems.  
 
Type 2 diabetes is increasing among those who are overweight or obese, physically 
inactive or have a family history of diabetes. There are also significant inequalities 
in developing diabetes. Type 2 diabetes, is up to six times more common in people 
of South Asian descent and up to three times more common in those of African and 
Afro-Caribbean descent, compared with the white population.  Type 2 diabetes is 
also more prevalent among less affluent populations; those in the most deprived 
fifth of the population are one-and-a-half times more likely to have diabetes at 
any given age.  Both mortality and morbidity, in relation to diabetes, are increased 
by socio-economic deprivation. Morbidity resulting from diabetes complications, is 
three-and-a-half times higher in social class V than social class I.95 96 
 
 
Where community  pharmacy can be ef fective 
 
The Evidence Base Review found that within community pharmacy both monitoring 
and information giving around diabetes, and group education showed promise in 
improving diabetic control. Since the Evidence Base Review was completed, 
further peer-reviewed evidence on the contribution of community pharmacy to 
improving health in relation to diabetes has been published. In the US, a 5-year 
                                                 
94 Department of Health (2002) Tackling Health Inequalities: 2002 Cross Cutting Review.  Department of Health: London. 
www.doh.gov.uk/healthinequalities/ccsrsummaryreport.htm  
95Department of Health (Standards – 2001, Delivery Strategy 2003) The National Service Framework for diabetes.  Department 
of Health: London.www.doh.gov.uk/nsf/diabetes  
96 Department of Health (2002) Tackling Health Inequalities: 2002 Cross Cutting Review.  Department of Health: London. 
www.doh.gov.uk/healthinequalities/ccsrsummaryreport.htm  
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study showed that interventions by community pharmacists for patients with Type 
2 diabetes were both clinically and cost-effective.97 In Australia, a trial of a disease 
management service, provided by community pharmacists for patients with Type 2 
diabetes, showed a significant improvement in patients’ adherence to 
medication.98 In the UK, preliminary results from a study of people with Type 2 
diabetes, showed that a fifth of study participants had poor understanding of the 
condition and that lifestyle modification was needed in a similar proportion of 
them.  The study also investigated the contribution community pharmacists could 
make to identifying, understanding and meeting the needs of patients with 
diabetes in collaboration with other healthcare professionals.99 These findings 
indicate that diabetes management services should be piloted in the UK as soon as 
possible.  
 
Recommendations: 
• Piloting of community pharmacy-based monitoring, management and public 
education of diabetes.   
• Establish appropriate infrastructure support to enable pharmacy to contribute 
effectively in co-operation with other health professionals and related services. 
• Further research on the contribution community pharmacy can make to 
improving the public’s health in relation to diabetes. 
  
 
Asthma  
 
Over 5.1 million people in the UK have asthma, which equates to around 1 in 13 
adults.100  One in eight children in the UK are currently being treated for asthma.101 
On average, 1,500 people die from asthma each year in the UK and about a third of 
deaths (34%) caused by asthma occur in people under the age of 65. Overall there 
has been an increase of about 50% in the prevalence of childhood asthma over the 
last 30 years. There has been at least a ten-fold increase in hospital admissions for 
asthma among children, which may partly reflect changes in medical practice.102 
 
 
Where community  pharmacy can be ef fective 
 
Evidence shows that educational interventions by pharmacists are effective in 
enhancing asthma knowledge of primary school teachers.  Further research is 
                                                 
97 Cranor CW, Bunting BA, Christensen DB.(2003) The Ashevile Project: long-term clinical and economic outcomes of a 
community pharmacy diabetes care program. J Am Pharm Assoc; 43 (2) 173-184 
98 Krass I, Stephenson S, Thuis I, Hourihan F, Taylor S, Armour C. (2002) Increasing adherence to medications through delivery 
of a disease management service for Type 2 diabetes in community pharmacies. J Soc Admin Pharm; 19 (6) 211 
99 Rajaei-Dehkordi Z, Hollingshead C, Herkes D, Holden M, Rao S. (2003) Invstigating the contribution of community 
pharmacists in identifying, understanding and meeting the needs of patients with diabetes, in collaboration with other health care 
professionals. Int J Pharm Pract; 11: R18 
100 www.asthma.org.uk  
101 www.asthma.org.uk  
102 Department of Health (1995) Great Britain Committee on the Medical Effects of Air Pollutants Great Britain: Asthma and 
outdoor air pollution.  The Stationery Office: London. www.doh.gov.uk/comeap/statementsreports/airpol2.htm  
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required to determine whether pharmacist-led training programmes can lead to 
improved management of asthma in schoolchildren by teachers. 
 
Recommendations: 
• Pharmacist-led asthma training programmes in schools to be rolled out 
nationally. 
• Further research to determine the extent to which pharmacist-led asthma 
training programmes lead to improved management of asthma in schoolchildren 
by teachers. 
• Establish appropriate infrastructure support to enable pharmacy to contribute 
effectively in co-operation with other health professionals and related services. 
 
 
Prevention of  teenage pregnancy 
 
In 2001, the number of 15-19 year olds who became pregnant in England and Wales 
was 60.9 in every thousand and 70.6 per thousand in Scotland. The rate of 
conceptions amongst 13-15 year olds was 8 in every thousand in England and 
Wales and 7.6 per thousand in Scotland.  Conception data is not collected in 
Northern Ireland; the only available statistics are for teenage births. In 2001, the 
number of teenage mothers was 1,524, a rate of 23.9 per thousand 15-19 year olds.  
Teenage pregnancy is linked to health inequalities, girls from the poorest 
backgrounds are ten times more likely to become teenage mothers compared to 
girls from professional backgrounds.103 These children are at high risk of growing 
up in poverty and experiencing poor health and social outcomes. Infant mortality 
rates for babies born to mothers under the age of 18 are 60% higher than for older 
mothers.104 The effect of halving the number of teenage births would by itself 
achieve an estimated 10% target reduction in infant mortality rates. 105 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                 
103 Department of Health (2002) Tackling health inequalities: 2002 crosscutting review.  Department of Health: London.  
www.doh.gov.uk/healthinequalities/ccsrsummaryreport  
104 www.brook.org.uk  
105 Department of Health (2002) Tackling health inequalities: 2002 crosscutting review.  Department of Health: London.  
www.doh.gov.uk/healthinequalities/ccsrsummaryreport  
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Teenage pregnancy targets:   
• Reduce the under-18 conception rate by 50% by 2010. (England)106 
• Achieve agreed local teenage conception reduction targets while reducing the 
gap in rates between the worst fifth of wards and the average by at least a 
quarter in line with national targets.(England)107 
• Reduce inequalities in health outcomes by 10%, measured by infant mortality 
and life expectancy at birth by 2010. (England)108 
• Reduce pregnancy rate among 13-15 year olds by 20% between 1995 and 2010. 
(Scotland)109 
• Reduce the rate of births to teenage mothers by 20% by 2007 (19 years and 
under). (Northern Ireland)110 
• Reduce the rate of births to teenage mothers under 17 by 40% by 2007. 
(Northern Ireland)111 
• 75% of teenagers should not have experienced sexual intercourse by the age of 
16 by 2007. (Northern Ireland)112 
 
 
Where community  pharmacy can be ef fective 
 
The Evidence Base Review found that there is a desire by the public for easy 
access to information on both contraception and safer sex and that they would be 
willing to receive this advice from pharmacists.  Pharmacists appear to want an 
expanded advisory role in sexual health. Access to training that incorporates and 
encourages networking with other local service providers is likely to be crucial in 
increasing pharmacists’ confidence in dealing with these issues appropriately and 
effectively.  
 
Community pharmacy has already made a considerable and well-documented 
contribution to reducing teenage pregnancy through over-the-counter provision of 
emergency hormonal contraception (EHC). The Evidence Base Review found, that 
this service had high levels of user satisfaction and that pharmacists are positive 
about their experience of providing emergency hormonal contraception.   The 
Review also found that the supply of EHC through pharmacy enables most women 
to receive EHC within 24 hours of unprotected intercourse and is highly rated by 
women as a source of EHC. Since the review was completed, further peer-reviewed 
evidence on the contribution of community pharmacy to the sexual health agenda, 
                                                 
106 Department of Health (2002) Improvement, expansion and reform: the next 3 years.  Priorities and planning framework 2003 
– 2006. Department of Health: London. www.doh.gov.uk/planning2003-2006 
107 Department of Health (2002) Improvement, expansion and reform: the next 3 years.  Priorities and planning framework 2003 
– 2006. Department of Health: London. www.doh.gov.uk/planning2003-2006 
108 Department of Health (2002) Improvement, expansion and reform: the next 3 years.  Priorities and planning framework 2003 
– 2006. Department of Health: London. www.doh.gov.uk/planning2003-2006 
109 The Scottish Office (1999) Towards a Healthier Scotland – A White Paper on Health. The Stationery Office: Scotland. 
www.scotland.gov.uk 
110 Department of Health, Social Services and Public Safety (2002) Teenage Pregnancy and Parenthood Strategy and Action. 
DHSSPS: Belfast Planwww.dhsspsni.gov.uk/publications/2003/teenage_pregnancy_action02_07.pdf 
111 Department of Health, Social Services and Public Safety (2002) Teenage Pregnancy and Parenthood Strategy and Action. 
DHSSPS: Belfast Planwww.dhsspsni.gov.uk/publications/2003/teenage_pregnancy_action02_07.pdf 
112 Department of Health, Social Services and Public Safety (2002) Teenage Pregnancy and Parenthood Strategy and Action. 
DHSSPS: Belfast Planwww.dhsspsni.gov.uk/publications/2003/teenage_pregnancy_action02_07.pdf 
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in relation to providing EHC, has been published.  In semi-covert research in 
Manchester, Salford and Trafford Health Action Zone, two female researchers 
posed as clients seeking EHC in a number of community pharmacies. The protocol 
for supply was largely adhered to and emergency hormonal contraception was 
supplied appropriately. The length of each consultation was between 10-15 
minutes and the pharmacists were courteous, polite and non-judgemental. The 
consultations were carried out in a private area or in the dispensary and no 
concerns about confidentiality were found.113 Another study found that users 
noted a welcome absence of judgmental attitudes when accessing the service.114  
 
Pharmacists identified many benefits of pharmacy supply of EHC, in particular the 
improved access to EHC at no cost to clients, the confidential nature of the scheme 
and also the potential for sign-posting users to other service providers.115 
 
Community pharmacies hope to develop this service further in order to meet 
women’s needs at a local level, particularly through increased use of Patient Group 
Directions to supply EHC to under-16-year olds. PCTs need to consider how 
pharmacies might contribute to national and local strategies for reducing teenage 
pregnancy. 
 
Recommendations: 
• PCTs need to consider how pharmacies might play a greater part in national 
and local sexual health strategies and also in reducing teenage pregnancy 
rates. 
• That pharmacy supply of EHC under Patient Group Direction leads to 
pharmacy-based services becoming more integrated with other local services 
increasing referrals between major service providers. 
• Establish appropriate infrastructure support to enable pharmacy to contribute 
effectively in co-operation with other health professionals and related services. 
 
 
Folic acid  and pregnancy 
 
Research has shown that pregnant women who take more folic acid when their 
baby’s spine is forming, greatly reduce the risk of their baby having a neural tube 
defect, such as spina bifida.116  There are around 90 babies born each year 
affected by neural tube defects in England and Wales, and around 70 in Scotland 
and 15 in Northern Ireland.  The total number of pregnancies affected by neural 
tube defects is not known, but is estimated to be 600-1,200 a year in the UK.  A 
                                                 
113 Anderson .C., Bissell .P. (2003 In Press) Using semi covert research to evaluate an emergency hormonal contraception 
service. Pharmacy World Science  
114 Bissell,P and Anderson, C (2003) Supplying emergency contraception via community pharmacies in the UK: reflections on 
the experience of  users and providers. Social Science and Medicine 57,12, 2367-2378 
115 Bissell,P and Anderson, C (2003) Supplying emergency contraception via community pharmacies in the UK: reflections on 
the experience of  users and providers. Social Science and Medicine 57,12, 2367-2378 
Bissell .P., Savage .I., Anderson .C. A Qualitative (2004 In Press) study of pharmacists' perspectives on the supply of emergency 
hormonal contraception via Patient Group Direction in the UK. 
116 Seashore. M.R., Cho, S.C.,Deposito. F. et al (1993) Folic acid and the prevention of neural tube defects’.  Paediatrics, 92: 
493-494. 
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number of these are aborted spontaneously and a further proportion are 
terminated around 20 weeks of gestation.117 
 
Where community  pharmacy can be ef fective 
 
Pharmacy staff are positive about promoting the role of folic acid in pregnancy and 
staff reported feeling comfortable discussing this issue with customers they knew, 
suggesting it is a sensitive topic.  The attitudes of general practitioners had an 
influence on whether pharmacists placed a folic acid health promotion sticker on 
certain products, suggesting there is a need to integrate pharmacy health 
promotion into the wider public health workforce. Further research is needed to 
establish the effect of pharmacy-based folic acid health promotion interventions. 
 
Recommendations: 
• Integrate pharmacy health promotion into the wider public health workforce. 
• Research the effectiveness of pharmacy folic acid health promotion 
interventions. 
• Establish appropriate infrastructure support to enable pharmacy to contribute 
effectively in co-operation with other health professionals and related services. 
 
 
Mental health 
 
Mental health problems can affect anyone, rich or poor, young or old, shattering 
the lives of those affected and the lives of the people close to them. One in four 
people experience a mental health problem at some point in their lives. Each year 
more than 250,000 people are admitted to psychiatric hospitals and over 4,000 
people take their own lives.118  Mental health problems range from more common 
conditions to deep depression to schizophrenia, which affects fewer than one 
person in a hundred. Mental illness is not well understood, it frightens people and 
all too often it carries stigma.119  There are high levels of health inequality with 
mental health problems, the proportion of adults assessed as having a neurotic 
disorder was 80% higher in social class V than in social class I in 1993.120  In terms of 
suicide, an unskilled working man is four times more likely to take his own life than 
a professional working man and rates in partly skilled and manual skilled workers, 
are twice as high as the professional group.121 
 
 
                                                 
117 Department of Health (2000) Consultation by the UK Health Departments and food Standards Agency on the report of the 
Medical Aspects of Food and Nutrition Policy (COMA) on Folic Acid and the Prevention of Disease.  Department of Health: 
London. www.doh.gov.uk/folicacid/folic.pdf  
118 www.mind.org.uk  
119 Department of Health (1999) Mental Health National Service Framework.  Department of Health: London. 
www.doh.gov.uk/nsf/mentalhealth.htm  
120 Department of Health (2002) Tackling Health Inequalities: 2002 Cross Cutting Review.  Department of Health: London. 
www.doh.gov.uk/healthinequalities/ccsrsummaryreport.htm  
121 Department of Health (2002) Tackling Health Inequalities: 2002 Cross Cutting Review.  Department of Health: London. 
www.doh.gov.uk/healthinequalities/ccsrsummaryreport.htm  
 32 
 
Mental Health targets: 
• Reduce the suicide rate and deaths by undetermined causes by 20% by 2010. 
(England)122 
• Reduce the proportion of people with a potential psychiatric disorder (as 
measured by the GHQ-12 score) by a tenth by 2010. (Northern Ireland)123 
 
 
Where community  pharmacy can be ef fective 
 
There is, as yet, little evidence about the contribution community pharmacy could 
make to improving the public’s mental health. However, because pharmacy users 
purchase products to reduce stress and anxiety and take up related leaflets 
available in pharmacies, particularly on sleep problems and relaxation, there may 
be future scope for appropriately trained pharmacists to offer more support and 
advice. Pharmacists already successfully offer and provide help on other sensitive 
issues, such as head lice treatment, emergency hormonal contraception and needle 
exchange, illustrating the potential role community pharmacy could occupy in 
supporting and referring people with mental health problems. Establishment of 
appropriate infrastructure support to enable pharmacy to contribute effectively in 
co-operation with other health professionals and related services is needed.  A first 
step would be to ensure that pharmacists have appropriate information about 
other relevant local services and to set up and evaluate pilot projects. 
 
Recommendations: 
• Set up pilot projects to determine whether there is a role for pharmacies 
regarding support, advice and referral for mental health issues. 
• Integrate pharmacy-based services into other relevant local services.  
• Establish appropriate infrastructure support to enable pharmacy to contribute 
effectively in co-operation with other health professionals and related services. 
 
 
Drug Use 
 
The social and economic costs of drug use in the UK amounted to £4 billion in 
2001, with most of this incurred by drug related crime. Drug use can be linked to 
poverty, homelessness, unemployment and crime.124  Therefore the problems of 
drug use require integrated solutions and co-ordinated delivery of services 
involving education, enforcement, social, economic and heath policies. Tackling 
drug use requires effective joint working between Government Departments at 
national level and similar partnership working between agencies at local level.125 
                                                 
122 Department of Health (2002) Improvement, expansion and reform: the next 3 years.  Priorities and planning framework 2003 
– 2006. Department of Health: London. www.doh.gov.uk/planning2003-2006 
123 Department of Health, Social Services and Public Safety (2002) Investing for Health.  DHSSPS: Belfast  
www.dhsspsni.gov.uk/publications/2002/invest1.pdf 
124 The National Assembly for Wales (2000) Tackling Substance Misuse in Wales: A Partnership Approach.  The National 
Assembly for Wales: Wales. 
125 Government (1998) Tackling drugs to build a better Britain. The Stationery Office: London. 
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Drug misuse targets: 
• Increase the participation of problem drug users in drug treatment 
programmes by 55% by 2004 and by 100% by 2008 and increase year on year 
the proportion of users successfully sustaining or completing treatment 
programmes. (England)126 
• Reduce the proportion of people under the age of 25 reporting the use of Class 
A drugs and reduce frequent use of any illicit drug amongst young people, 
especially by the most vulnerable young people. (England)127 
• Reduce drug-related deaths by 20% by 2004 (against 1999 baseline). 
(England)128 
 
 
Where community  pharmacy can be ef fective 
 
The Evidence Based Review found that community plays an important role in 
tackling some of the problems of drug use and that community pharmacy-based 
drug use services are highly valued by drug users. Pharmacy-based needle-
exchange schemes are cost-effective and supervised methadone administration 
services achieve high attendance rates and are acceptable to clients.  Positive 
pharmacist attitudes are correlated with higher service provision for drug users, 
however, practising pharmacists appear to have more negative opinions about 
drug users than undergraduate pharmacy students.  Training is needed to address 
translating technical terms into an appropriate language for drug users. 
 
Recommendations: 
• Establish community pharmacy-based services for drug users in all areas. 
• Train pharmacists and their staff in providing services to ensure safe and 
appropriate services for both users and staff. This should include awareness of 
the needs of the target group and of cultural barriers. 
• Establish appropriate infrastructure support to enable pharmacy to contribute 
effectively in co-operation with other health professionals and related services. 
 
 
1 .2 Health Improvement:  Communities 
 
Health inequali ties 
 
During the twentieth century there have been considerable improvements in the 
nation’s overall health.   For example, life expectancy at birth for women is now 80 
                                                                                                                                           
www.archive.official-documents.co.uk/document/cm39/3945/3945.htm  
The Home Office (2002) Updated Drug Strategy 2002.  The Home Office: London. 
www.drugs.gov.uk/ReportsandPublications/NationalStrategy/1038840683/Updated_Drug_Strategy_2002.pdf  
126 Department of Health (2002) Improvement, expansion and reform: the next 3 years.  Priorities and planning framework 2003 
– 2006. Department of Health: London. www.doh.gov.uk/planning2003-2006 
127 Department of Health (2002) Improvement, expansion and reform: the next 3 years.  Priorities and planning framework 2003 
– 2006. Department of Health: London. www.doh.gov.uk/planning2003-2006 
128 Department of Health (2002) Improvement, expansion and reform: the next 3 years.  Priorities and planning framework 2003 
– 2006. Department of Health: London. www.doh.gov.uk/planning2003-2006 
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years compared with 48 in 1900; for men it is 75, compared with 44. Over the same 
period, infant mortality fell from over one in ten to six per 1,000.   Unfortunately 
these improvements have not always been achieved at a similar rate among all 
social groups, or in all parts of the country. In particular, people in lower socio-
economic groups tend to be ill more often, to die sooner129 and suffer more long-
standing and limiting illnesses.  The death rate in men under 65 years is 1.6 times 
higher in the North West than in the South East.  In Manchester, the death rate for 
people under 65 years is over three times higher than in Kingston and Richmond.130 
 
People are born into situations of inequality, which continue throughout life. 
Health inequalities cross generations, affecting the life chances and quality of life 
of adults, their children and their grandchildren.131 Babies born to poorer families 
are more likely to be premature, are at greater risk of infant mortality. They have a 
greater likelihood of suffering poverty, impaired development and chronic 
diseases later in life.  Babies with fathers in social classes IV and V have a birth-
weight that is on average 130 grams lower than that of babies in social classes I and 
II. Low birth-weight is closely associated with death in infancy, as well as heart 
disease, diabetes and hypertension in later life.  
 
Health inequali ties targets: 
• Reduce inequalities in health outcomes by 10% as measured by infant 
mortality and life expectancy by 2010. (England).132 
• Reduce the gap in life expectancy between those living in the fifth most 
deprived electoral wards and the average life expectancy by 50% for both men 
and women by 2010. (Northern Ireland).133 
• Health Headline Targets for the period 1995 to 2010: Reduce premature 
mortality from Coronary Heart Disease by 50%.  Reduce premature mortality 
from Cancer by 20%. Reduce smoking among 12-15 year olds from 14% to 11%.  
Reduce the proportion of women smoking during pregnancy from 29% to 20%. 
Reduce incidence of men and women exceeding weekly alcohol limits from 33% 
to 29% and 13% to 11% respectively. Reduce teenage pregnancy rate among 
13-15 year olds by 20%.  60% of 5 year old children with no experience of 
dental disease. For each of these targets, there is an inequalities gap, which will 
be regularly measured to assess progress in reducing the disparity in health 
status between different socio-economic groups. (Scotland).134 
• The Welsh Assembly proposes to develop, in consultation with key agencies, a 
number of priority targets for the reduction of inequalities in health in Wales.135 
                                                 
129 Department of Health (2002) Our Healthier Nation: Reducing Health Inequalities: an Action Report. Department of Health: 
London 
130 Department of Health (2002) Tackling Health Inequalities: 2002 Cross Cutting Review.  Department of Health: London. 
www.doh.gov.uk/healthinequalities/ccsrsummaryreport.htm 
131 Department of Health (2002) Tackling Health Inequalities: 2002 Cross Cutting Review.  Department of Health: London. 
www.doh.gov.uk/healthinequalities/ccsrsummaryreport.htm  
132 Department of Health (2002) Improvement, expansion and reform: the next 3 years.  Priorities and planning framework 2003 
– 2006. Department of Health: London. www.doh.gov.uk/planning2003-2006 or  www.doh.gov.uk/healthinequalities  
133 Economic Policy Unit (2003) Building on Progress: Priorities and Plans 2003-2006. www.pfgni.gov.uk.Ecomonic Policy 
Unit: Northern Ireland. 
134 The Scottish Office (1999) Towards a Healthier Scotland - A White Paper on Health.  The Scottish Office: The Stationery 
Office. www.scotland.gov.uk/library/documents-w7/tahs-00.htm  
135 Secretary of State for Wales (1998) Better Health Better  Wales.  The Stationery Office 
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Where community  pharmacy can be ef fective 
 
Community pharmacy, based in the heart of communities, could be used to 
improve access and quality of primary care services in deprived areas. 
Pharmacists are very positive about the need for health improvement activities in 
the pharmacy and their role in delivering this. The Evidence Based Review found a 
number of interesting, but anecdotal case studies of how community pharmacy 
might contribute to reducing health inequalities.  Whilst this Evidence remains 
anecdotal and was largely excluded from the Evidence Base by the selection 
criteria, there is significant value to be gained from examining it with a view to 
identifying and conducting further research into the potential role that community 
pharmacy might take in reducing inequalities. An appropriate infrastructure 
support to enable pharmacy to contribute effectively to reducing health 
inequalities in co-operation with other health professionals and related services, 
must be established. 
 
Recommendations: 
• Further research to determine where pharmacist can effectively contribute to 
reducing health inequalities.   
• Establish appropriate infrastructure support to enable pharmacy to contribute 
effectively in co-operation with other health professionals and related services. 
 
 
Health education  
 
The main source of pharmacy public health information is in the form of leaflets, 
which cover health issues such as folic acid, stopping smoking, oral health, and 
depression.  The Evidence Based Review found community pharmacists consider 
health information leaflets to be an important component of their health 
improvement toolkit and that pharmacy users who have received health advice are 
positive about the service and gained useful health information. However, a high 
number of pharmacists report that they have never received training or guidance 
on using leaflets.  Also, the public don’t immediately recognise pharmacists as a 
source of general health advice and passive displays of leaflets in the pharmacy 
may be missed by half of pharmacy customers. The Evidence Based Review found 
that frequent users of pharmacies, particularly those taking prescribed medicines, 
are more likely to take and read pharmacy health information leaflets and view the 
pharmacist as a source of general health advice, probably because they have had 
more contact with the pharmacist. This suggests that leaflet-based strategies to 
raise public awareness and knowledge of health issues may be more effective if 
they are considered as supporting medicines or health advice, or offering an 
opportunity for discussion, rather than as an end in themselves. Community 
pharmacy has been identified as a promising setting for behaviour change 
interventions due to the frequency of contacts between the public and the health 
professional.  A ‘brief intervention’ is a time-limited (5-10 minutes) interaction 
between the health professional and client with a focus on changing client 
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behaviour. The method has been used in modifying a range of health behaviours 
including smoking, physical activity, adherence to diet in diabetes, weight control, 
alcohol moderation, domestic violence and safe sex. There is evidence of the 
efficacy of brief interventions and the use of this method in primary care by 
pharmacists has considerable potential to improve the public’s health. The 
Evidence Base Review suggested that pharmacists could develop their advice-
giving role further by proactively offering advice and leaflets.  More evidence is 
required on the relationship between increased interaction with pharmacy staff 
and changes in clients’ behaviour or health outcomes.  
 
Although there is no doubt that leaflets are still the core communication device in 
many situations, there is mounting evidence to suggest that how patients receive 
health information should relate to their individual preferences.  In order to appeal 
to a much wider audience, other methods of communication need to be utilised.  
Currently there is insufficient evidence to suggest that one particular form of 
information presentation is more effective than any other. When a pharmacist or 
other staff member actively engages with patients, it may be possible to determine 
what method of information provision would suit them best. For example touch-
screen kiosks in pharmacies seem more likely to appeal to younger people (under 
40 years old). 
 
 
Recommendations: 
• Pharmacists need to consider the most appropriate ways of ensuring their 
users have access to the information they need. 
• Leaflet-based strategies to raise public awareness and knowledge of health 
issues should be used as an opportunity for discussion, rather than as an end 
in themselves. 
• When neither pharmacy users nor the pharmacist may be able, or willing, to 
engage in further consultation, easily accessible written or electronic health 
information should be available to those who require it. 
• Further research is needed to explore the potential to develop the information 
and advice-giving role of community pharmacists further, for example through 
pharmacists proactively offering advice and leaflets. 
• As service developments occur it may be necessary to run local campaigns to 
raise public awareness of services on offer and to target those who would 
benefit most from increased access such as those living in areas of deprivation 
or inner cities. 
• Establish appropriate infrastructure support to enable pharmacy to contribute 
effectively in co-operation with other health professionals and related services. 
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1.3 Health Protection 
 
Prevention and transmission of  infection 
 
Infectious diseases are a major global threat to health, prosperity, social stability 
and security. Infectious diseases account for 41% of the global disease burden 
with infections such as HIV/AIDS, tuberculosis and malaria accounting for millions 
of deaths in the world each year. A number of important factors increase the risk to 
human health from infectious diseases, these include global travel, adaptation of 
micro-organisms and changes in environment and land use.136  
 
In England, although the major infectious diseases kill only a small number of 
people compared to the past, infection is still important. For example 40% of 
people consult a health professional each year because of infection and infections 
account for 70,000 deaths each year. A number of major national crises over the 
last few years have been a direct consequence of infectious diseases such as BSE 
and CJD, foot and mouth disease, deaths of children and students from meningitis, 
NHS winter pressures from influenza and bronchitis and the Lanarkshire E. coli 
O157 outbreak.  The number of people living with diagnosed Human 
Immunodeficiency Virus (HIV) in England is estimated to rise to 29,000 by the end 
of 2003, an increase of 40% from 1999.  The potential threats to health from 
infectious diseases in England today are diverse and include: the threat of new or 
previously unrecognised diseases, animal diseases that can transmit to humans, 
poor hygiene, slack disease control measures and poor standards of medical 
care.137 
 
 
Immunisation 
 
Immunisation protects individuals and the community from serious diseases. There 
are some diseases that can kill children or cause lasting damage to their health, 
and sometimes a child's immune system needs help to fight those diseases. 
Childhood immunisation provides that help.  For example, in the years before the 
measles vaccine was introduced, an average of 250,000 cases were recorded 
annually in England and Wales, and 85 children died. In 1999, 2,438 cases were 
recorded and two people died both from the later effects of the disease caught in 
the 1980s or before. Immunisation also plays an important part in protecting 
people throughout their lives, whether through the meningitis C vaccine for 
students, or influenza (flu) vaccination for those aged 65 years and over. 
Immunisation also helps protect people when travelling abroad.138 
 
 
                                                 
136 Department of Health (2002) Getting Ahead Of The Curve: A strategy for combating infectious diseases (including other 
aspects of health protection).  A report by the Chief Medical Officer.  Department of Health: London. 
137 Department of Health (2002) Getting Ahead Of The Curve: A strategy for combating infectious diseases (including other 
aspects of health protection).  A report by the Chief Medical Officer.  Department of Health: London. 
138 www.doh.gov.uk/immunisation/index.htm  
 38 
Immunisation targets: 
• 70% uptake in influenza immunisation in people aged 65 years and over, 
targeting populations in the 20% of areas with the lowest life expectancy. 
(England)139 
 
 
Where community  pharmacy can be ef fective 
 
The Evidence Based Review found that immunisation services can be provided 
safely through community pharmacies, and that pharmacy patient medication 
records are effective in identifying ‘at risk’ clients who can then be invited for 
immunisation.  User satisfaction with this service is high and support for non-
physician immunisation was found to be greater for adult than for child 
immunisation. Pharmacy could make a significant contribution to the flu 
immunisation target by supplying influenza immunisation for the elderly through 
pharmacy. Older people are often in regular contact with their pharmacists, this 
provides an opportunity for pharmacists to proactively approach and advise 
immunisation. 
 
Recommendations: 
• The potential to use pharmacy based patient medication records to target 
people for flu immunisation is considerable and should be piloted in the UK.  
• Community pharmacy provision of flu immunisation should be piloted in the 
UK. 
• Establish appropriate infrastructure support to enable pharmacy to contribute 
effectively in co-operation with other health professionals and related services. 
 
 
Head l ice 
 
Head lice are small, six-legged wingless insects, pin-head size when they hatch, 
less than match-head size when fully grown and grey/brown in colour. They very 
often cause itching, but this is not always the case, particularly when recently 
arrived on the head.  Head lice cannot fly, jump or swim, but spread from head to 
head. Anyone with hair can catch them, but children who have head-to-head 
contact, either at school or during play, are most commonly affected.140 
  
Head l ice targets: 
•  None found 
 
 
 
 
                                                 
139 Department of Health (2002) Improvement, expansion and reform: the next 3 years.  Priorities and planning framework 2003 
– 2006. Department of Health: London. www.doh.gov.uk/planning2003-2006 
140 www.doh.gov.uk/headlice/index.htm  
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Where community  pharmacy can be ef fective 
 
The Evidence Base Review found evidence to support the involvement of 
community pharmacy in head lice monitoring and treatment.  Members of the 
public see pharmacists as an approachable source of advice and treatment for 
head lice and pharmacists and health professionals are positive about the service 
and would like to see it continue.  Pharmacists followed the protocol requirement 
for examination and proof of infection efficiently and where treatment was 
supplied, community pharmacists’ adherence to the local formulary appears to 
have been extremely high, approaching 100%.  Further research to assess the 
effectiveness and cost-effectiveness of these pharmacy-based interventions, is 
required, together with the need for local planning and co-ordination of treatment 
services and messages.  Due to the sensitivity of this issue, a private consultation 
area in the pharmacy should be established. 
 
Recommendations: 
• Community pharmacy head lice advice and treatment services rolled-out across 
the UK. 
• Research to assess the effectiveness and cost-effectiveness of pharmacy-based 
head lice interventions.  
• Local planning and co-ordination of head-lice treatment services and messages.  
• Establish appropriate infrastructure support to enable pharmacy to contribute 
effectively in co-operation with other health professionals and related services. 
 
 
Sexually  transmitted infections 
 
Since 1995 there has been a rise in the diagnosis of acute sexually transmitted 
infections (STIs) such as genital chlamydia, gonorrhoea, syphilis and genital warts. 
Chlamydia cases increased by 165% between 1995 and 2002, gonorrhoea increased 
by 145% and syphilis, though affecting only a small number of people, increased 
by 777%. In particular, there have been large and increasing numbers of diagnoses 
among teenage women and men who have sex with men. This may be because 
more people are aware of STIs and are visiting clinics to be tested, but risky 
behaviour continues to be a factor in the increase.  Genito-Urinary Medicine (GUM) 
clinics in England, Wales and Northern Ireland diagnosed 81,680 cases of 
chlamydia, 69,417 cases of genital warts, 24,953 cases of gonorrhoea, 18,392 cases 
of genital herpes and 1,193 cases of syphilis in 2002. Figures for Scotland are not 
currently available.  2002 saw the largest annual number of newly diagnosed HIV 
infections with 5,338 cases reported. It is estimated that 41,200 people are living 
with HIV in the United Kingdom, around a third of whom are undiagnosed.  There is 
a strong link between social deprivation and STIs. For example the rates of 
gonorrhoea in some inner city black and minority ethnic groups are ten or eleven 
times higher than in whites. There is also evidence of considerable lack of 
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information amongst young people about sexually transmitted infections and how 
to protect against them.141 
 
Sexually  Transmitted Infection targets: 
•  None found 
 
 
Where community  pharmacy can be ef fective 
 
The Evidence Based Review found that there is the potential to increase the role of 
pharmacy in preventing the transmission of infection and pharmacists are positive 
about undertaking this role. In order to expand this role pharmacists need a 
supporting infrastructure in place including: training, appropriate reimbursement 
and an area in the pharmacy for private consultations. Further exploration and 
research into their potential role is required.  
 
Recommendations: 
• A supporting infrastructure be put in place including; training, appropriate 
reimbursement and an area in the pharmacy for private consultations. 
• Research further where pharmacists can contribute effectively in prevention of 
sexually transmitted infections. 
 
 
Travel  Health 
 
Every year, residents of the United Kingdom go on more than 56 million overseas 
journeys. The following are driving factors associated with increased infection from 
travel: 
 
• Air travel makes it possible to spread infectious diseases to different 
parts of the world; 
• People are travelling to areas where they can become infected and 
bring new diseases home with them; and 
• The speed of travel enables a person carrying a disease such as Ebola 
to travel 12,000 miles and pass unnoticed through customs and 
immigration before developing symptoms several days later; infecting 
many other people before becoming ill.142 
 
 
Travel  Health targets: 
•  None found 
 
 
 
                                                 
141 www.brook.org.uk 
142 Health Protection Agency www.hpa.org.uk  
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Where community  pharmacy can be ef fective 
 
The Evidence Based Review found that at present, pharmacy involvement in 
preventing the transmission of infection, currently centres on opportunistic travel 
health advice. However, there is the potential to increase this role. In order to 
expand this role, pharmacists need to have a supporting infrastructure in place 
including: training, appropriate reimbursement and an area in the pharmacy for 
private consultations. Further exploration and research into their potential role is 
urgently required. Due to the sensitivity of this issue a private consultation area in 
the pharmacy should be established. 
 
Recommendations: 
• A supporting infrastructure is put in place including training, appropriate 
reimbursement and an area in the pharmacy for private consultations. 
• Research further where pharmacists can contribute in giving travel health 
advice. 
 
 
Injury  Prevention 
 
Accidental injury  
 
Accidental injury is a significant public health issue, particularly for children and 
older people. Every year 10,000 people die from accidental injury; it is the leading 
cause of death among children aged 0-14 years. In addition, there are many 
millions of non-fatal accidents each year, around 2.8 million of them occur in the 
home, many caused by falls.143  
 
Falls are a major cause of disability and the leading cause of mortality due to 
injury in older people aged over 75 in the UK.  Up to 14,000 people a year, die in 
the UK, as a result of an osteoporotic hip fracture.144 Most falls do not result in 
serious injury, but there are serious consequences for an individual from falling or 
from not being able to get up after a fall.  These can include: loss of confidence, 
loss of mobility leading to social isolation and depression, increased dependency 
and disability, hypothermia, pressure-related injury and infection.145  
 
Accidental injury is also related to socio-economic factors. For example, residential 
fire deaths for children are 15 times greater for children in social class V compared 
with those in social class I and child pedestrian deaths are 5 times greater between 
these social classes.146 
                                                 
143 Department of Health (2002) Preventing Accidental Injury - Priorities for action: Report to the Chief Medical Officer from 
The Accidental Injury Task Force.  The Stationery Office: London. 
144 Department of Health (2001) National Service Framework for Older People.  Department of Health: London. 
www.doh.gov.uk/nsf/pdfs/nsfolderpeople.pdf  
145 Department of Health (2001) National Service Framework for Older People.  Department of Health: London. 
www.doh.gov.uk/nsf/pdfs/nsfolderpeople.pdf  
146 Department of Health (2002) Preventing Accidental Injury - Priorities for action: Report to the Chief Medical Officer from 
The Accidental Injury Task Force.  The Stationery Office: London. 
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Accidental injury  targets: 
• Reduce the mortality rate from suicide and undetermined injury by at least 
20% by 2010. (England)147 
• Improve the quality of life of older people so that they can live at home where 
ever possible, by increasing the number of those supported intensively to live 
at home, to 30% of the total being supported by social services at home or in 
residential care by 2006. (England)148 
• Each year less than 1% growth in emergency hospital admissions and no growth 
in re-admissions. (England)149 
• To reduce the death rate from accidents in people of all ages by at least one 
fifth between 2000 and 2010. (Northern Ireland)150   
• To reduce the rate of serious injuries from accidents in people of all ages by at 
least one tenth between 2000 and 2010. (Northern Ireland)151 
 
 
Where community  pharmacy can be ef fective 
 
The Evidence Based Review, found pharmacy can contribute to reducing 
accidental injury through pharmacy-based osteoporosis-screening services, 
involving pharmacist and nurse input.  This service was found to be accessible and 
valued by users and effective in identifying women at risk of osteoporosis in order 
to initiate health promotion interventions. 
 
Recommendations: 
• Establishment of pharmacy osteoporosis screening services across the UK. 
• Further research where pharmacy can contribute to injury prevention. 
• Establish appropriate infrastructure support to enable pharmacy to contribute 
effectively in co-operation with other health professionals and related services. 
 
 
Medicines related injuries 
 
Children and methadone related injuries 
Methadone use has been steadily increasing to tackle rising addiction problems in 
society. In the UK, deaths attributable to methadone poisoning fell from 37% in 
1997 to 18% in 1999 according to a study based in Yorkshire.152 This report also 
described that the proportion of deaths involving methadone fell despite 
                                                 
147 Department of Health (2002) Improvement, expansion and reform: the next 3 years.  Priorities and planning framework 2003 
– 2006. Department of Health: London. www.doh.gov.uk/planning2003-2006 
148 Department of Health (2002) Improvement, expansion and reform: the next 3 years.  Priorities and planning framework 2003 
– 2006. Department of Health: London. www.doh.gov.uk/planning2003-2006 
149 Department of Health (2002) Improvement, expansion and reform: the next 3 years.  Priorities and planning framework 2003 
– 2006. Department of Health: London. www.doh.gov.uk/planning2003-2006 
150 Department of Health, Social Services and Public Safety (2002) Investing for Health.  DHSSPS: Belfast  
www.dhsspsni.gov.uk/publications/2002/invest1.pdf 
151 Department of Health, Social Services and Public Safety (2002) Investing for Health.  DHSSPS: Belfast  
www.dhsspsni.gov.uk/publications/2002/invest1.pdf 
152 Oliver P, Keen J, Mathers N (2002) Deaths from drugs of abuse in Sheffield 1997-1999: what are the implications for GPs 
prescribing to heroin addicts? Family Practice19(1):93-4 
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increased prescribing. On the other hand, methadone has been implicated in child 
accidents and this indicates a need for thorough examination of methadone related 
child accidents.153 
 
Where community  pharmacy can be ef fective 
 
There is a need for the health professionals to join up with parents and community 
in an effort to curb these avoidable accidents. A simple strategy to prevent these 
kinds of accidents will be to promote the use of child resistant containers154 and to 
educate parents and carers to keep the medications safe.  Another preventative 
measure would be to conduct supervised administration of methadone.  With 
support from both health professionals and the local community, pharmacists 
could play a crucial role in these strategies.  
 
Recommendations: 
• Research to assess the effectiveness and cost-effectiveness of pharmacy-based 
supervised administration methadone  
• Community pharmacists should advice on keeping medicines safe 
• Establish appropriate infrastructure support to enable pharmacy to contribute 
effectively to the local drugs strategy in co-operation with other health 
professionals and related services. 
 
 
Older  peo ple and medicine related injuries 
 
As people get older, their use of medicines increases. Four out of five people over 
75 take at least one prescribed medicine and around 36% take four or more 
medicines.155   Alongside this, comes an increasing challenge to ensure that 
medicines are prescribed and used effectively. The ageing process affects the 
body’s capacity to handle medicines. Multiple diseases and complicated 
medication regimes, may also affect a patients capacity and ability to manage their 
own medication.156 This can have serious consequences and cause medicines 
related injuries such as falls and other accidents.157  It is generally accepted that 
any effective medicine will also have side effects. Many side effects are related to 
the way in which the medicine works to cause beneficial effects. Some side effects 
however, are not related to the way in which the medicine causes beneficial 
effects, and are unpredictable. Patients are all individuals and may respond in 
slightly different ways to the same medicine; it is therefore often impossible to 
                                                 
153 Towner E Dowswell T. (2002) 2001 Community-based childhood injury prevention interventions: what works? Health 
Promotion International17(3):273-84. 
154 Lawson GR, Craft AW, Jackson RH . Changing pattern of poisoning in children in Newcastle, 1974-81 Br Med J (Clin Res 
Ed). 1983 Jul 2;287(6384):15-7  
Krug A. Ellis J, Hay IT et al. The impact of child-resistant containers on the incidence of paraffin (kerosene) ingestion in 
children. S Afr Med J 1994 Nov;84(11):730-4 
155 Health Survey for England (1998) Volume 1: Findings. 
156 Department of Health (2001) Medicines and older people National Service Framework: Implementing medicines related 
aspects of the NSF for Older People.  Department of Health: London. www.doh.gov.uk/nsf/pdfs/medicinesbooklet.pdf.  
157 Cited in Health Education Authority (1999) Older people and accidents: Fact Sheet 2.  HEA: London. 
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predict how effective a medicine will be in treating a patient's medical condition, 
and whether the patient will have any side effects.158 
 
Medicines related injuries targets:  
• Improve the quality of life of older people so that they can live at home 
wherever possible, by increasing the number of those supported intensively to 
live at home, to 30% of the total being supported by social services at home or 
in residential care by 2006. (England)159 
• Each year less than 1% growth in emergency hospital admissions and no growth 
in re-admissions. (England)160 
 
 
Where community  pharmacy can be ef fective 
 
During the normal course of their work, pharmacists and their staff have a 
substantial amount of contact with older people and people who require repeat 
dispensing. This places them in an ideal position to be able to identify patients at 
risk of medicines related injuries.  
 
Recommendations: 
• Establish communication between local health professionals to set up a system 
of adapting prescribing patterns to changing patient needs. 
• Research further into the pharmacists’ role in preventing accidents in other 
target groups, for example children and young people. 
• Establish appropriate infrastructure support to enable pharmacy to contribute 
effectively in co-operation with other health professionals and related services. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                 
158 Committee on Safety of Medicines (CSM)/MHRA www.mca.gov.uk 
159 Department of Health (2002) Improvement, expansion and reform: the next 3 years.  Priorities and planning framework 2003 
– 2006. Department of Health: London. www.doh.gov.uk/planning2003-2006 
160 Department of Health (2002) Improvement, expansion and reform: the next 3 years.  Priorities and planning framework 2003 
– 2006. Department of Health: London. www.doh.gov.uk/planning2003-2006 
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2 Factors af fecting the ef fectiveness of  interventions 
 
In order for community pharmacists to carry out an extended public health role 
and deliver public health services through their pharmacies, a comprehensive 
underpinning support infrastructure must be developed.  Key components of this 
are outlined below. 
 
Training and facil itators 
 
The Evidence Base Review found that the provision of training and facilitators, 
positively increases the level of involvement of pharmacists in health promotion 
interventions. It also results in a greater uptake of services by clients, with 
increased satisfaction. This suggests that training and facilitation are key to 
increasing the acceptability and usefulness of interactions between pharmacists 
and clients over health promotion. Training and education can also link pharmacists 
more closely with primary care staff and local services, thus reducing the concerns 
of pharmacists over how pharmacy-based public health initiatives might be 
received by pharmacy users and other healthcare professionals. 
 
The Evidence Base Review, identified a number of specific health promotion areas 
where training was effective. For example, pharmacists delivering smoking 
cessation services, who had undergone training in smoking cessation techniques 
and behaviour change methods, were found to increase the effectiveness of the 
service by achieving higher quit rates.  Overall, training was found to increases 
knowledge, self-confidence and positive attitudes among pharmacists and their 
staff in relation to smoking cessation. Training in oral health and skin cancer 
prevention, was found to enhance knowledge and increase the opportunistic 
offering of advice to clients by pharmacists.   The Evidence Base Review also 
identified a specific training need for pharmacists participating in pharmacy-based 
needle-exchange schemes.  It was found that this training needs to include skills in 
translating technical terms into a suitable language for drug users. 
 
In summary, training and facil itation was found to: 
 
• Successfully produce behavioural change in pharmacists to a more holistic 
approach and understanding of health. 
• Increase the length of consultation with the clients. 
• Increase the effectiveness of interventions. 
• Increase local multi-agency working. 
• Increase the likelihood of pharmacists becoming more proactive in giving health 
information and advice. 
• Increase the likelihood of pharmacists becoming more likely to discuss general 
health issues and prevention, rather than focusing on medicine. 
• Increase clients’ satisfaction with the consultation.  
• Increase the likelihood of clients feeling able to ask questions. 
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Studies from the early 1990s, showed that most pharmacists felt that their 
education at undergraduate and pre-registration level, had not prepared them 
adequately for involvement in health development activities. Pharmacists have 
reported their undergraduate and pre-registration training, carried out in the late 
1980s as being ‘non-existent’ or ‘poor’ in preparing them for an advice-giving role. 
However, the investigation identified no recent data to allow comparisons with the 
current situation. Given the importance of training and education in delivering 
public health initiatives, research is urgently needed to determine current 
perceptions of recently qualified pharmacists on the training and education they 
received.  Also core pharmacy practitioner and specialist public health 
competencies need to be developed based around the Faculty of Public Health’s 
10 key areas for public health practice (as outlined).161 Underpinning these 
competencies must be a comprehensive training and education programme.   
 
Recommendations: 
• Development of core pharmacy public health competencies based around the 
Faculty of Public Health’s 10 key areas for public health practice. 
• Comprehensive training and education programme, to meet the needs of both 
pharmacy public health practitioners and specialists. 
• At a specialist level, joint training and registration between the Royal 
Pharmaceutical Society of Great Britain and the Faculty of Public Health. 
• The use of facilitators in public health interventions where appropriate.  
• Training for pharmacy-based needle-exchange schemes, including skills in 
translating technical terms into a suitable language for drug users. 
• Research current perceptions of newly and recently qualified pharmacists on 
the training and education they received. This research should particularly 
evaluate the pharmacists’ confidence in raising health issues with pharmacy 
users in an appropriate manner and readiness for greater communication with 
primary care staff. 
 
 
Remuneration 
 
The Evidence Base Review highlighted how infrastructure issues, particularly 
remuneration, can create a barrier to maximal use of community pharmacies to 
deliver services aimed at improving the public's health. The new contract for 
community pharmacy will be an important framework for delivering public health 
services in community pharmacy.  Under the new contractual framework, essential 
services, which would normally be provided by all community pharmacies, will 
include the promotion of healthy lifestyles and the promotion of self-care. The 
inclusion of public health in the essential services element of the new pharmacy 
contract recognises the importance of public health and the contribution that can 
be made by pharmacy contractors.  
 
                                                 
161 Faculty of Public Health – www.fph.org.uk 
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Recommendations: 
• That the new pharmacy contract rewards high-quality, patient-centred, 
effective interventions and encourage the maximum number of pharmacies to 
engage in public health activities. 
 
 
Information technology  
 
Community pharmacy must have the information technology expertise and 
capacity to provide services that are integrated into the wider health community.  
For example, pharmacy must be linked and able to access and annotate NHS 
electronic patient records to ensure effective and appropriate care. 
 
The current pharmacy IT infrastructure should be developed as there is 
substantial evidence indicating that using pharmacy records for screening and 
client identification purposes is effective and can be used for instigating health 
promotion measures.  This applies to a number of health topics including coronary 
heart disease, lipid management and immunisation. It is also relevant to a number 
of health topics marked down for further research, such as diabetes and obesity. 
Given the fact that both the ill and the healthy visit pharmacies, the use of 
pharmacy records, to identify and target public health interventions for individuals 
and communities, offers huge potential to improve the public’s health and reduce 
health inequalities.  
 
Recommendations: 
• Use community pharmacy patient medication records to identify and target 
public health interventions for individuals and communities. 
• Expand the IT capacity and expertise of pharmacy. 
• Link pharmacy electronically to the NHS.  
 
 
Design and use of  pharmacy premises 
 
The Evidence Base Review, found that the vast majority of pharmacy users 
(approximately 80%) reported satisfaction with privacy and confidentiality levels 
within community pharmacies.  In addition, some clients choose to use a pharmacy 
to maintain their anonymity. For example, research on emergency hormonal 
contraception supply, found that some women positively select a pharmacy where 
they are not known in order to preserve anonymity. However, a number of the 
areas in which pharmacists could potentially contribute to improving the public’s 
health, involve sensitive issues and users often emphasise the importance of 
confidentiality and privacy. For example: sexual health, head lice management and 
mental health. Clients may also self-select pharmacies on the basis of privacy level, 
where they have a choice.  Some clients reported intending to ask the pharmacist’s 
advice on a sensitive issue, but ultimately found themselves unable to do so 
because of concerns about privacy.  Pharmacists must respond to these needs, if 
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they are to expand their involvement in public health and provide a high level of 
user satisfaction. Facilities must be available to enable confidential consultations, 
especially when giving advice on sensitive topics. There is no commonly-accepted 
definition of what a consultation area is. A working definition might be “a separate 
area of the pharmacy that allows for confidential dialogue with patients and 
customers in appropriate surroundings”.  There are no national data on the 
numbers of community pharmacies that have a consultation area. Current 
estimates for England are 25-30%. 
 
Since the Evidence Review was completed, further evidence on consultation areas 
has been published. The large multiple groups are proposing to increase the 
spread of installation of consultation areas. We estimate that by the end of 2004 at 
least 40-45% community pharmacies will have such an area – and the installation 
rate is likely to be accelerated by the new requirements under the community 
pharmacy contract.   
 
From the limited evidence available, consultation areas appear to make a useful 
contribution to community pharmacy facilities. They are well regarded by the 
customers who use them as well as by pharmacists and their staff.  The available 
evidence suggests, that consultation areas are likely to be welcomed by the 
public.   The extent to which the presence of a consultation area will change the 
behaviour of those pharmacy users who do not currently access health advice and 
services from pharmacies is unknown.   Simply installing consultation areas without 
implementation support is, in itself, unlikely to be sufficient. The use of 
consultation areas is influenced by the attitudes and behaviour of pharmacists 
and their staff, as well as by customer attitudes.  At least initially, pharmacists and 
their staff will have to take a lead in using their consultation areas, until pharmacy 
users themselves become familiar with their purpose and benefits. Publicity and 
signage for consultation areas are also likely to influence their use. Pharmacy 
organisations can continue to promote the use of consultation areas and to 
disseminate examples of innovative practice.162 
 
Recommendations: 
• Facilities must be available to enable confidential consultations, especially 
when giving advice on sensitive topics. 
• To encourage the addressing of concerns about privacy, and to ensure that all 
users have access to the full range of pharmacy services, information about 
privacy, confidentiality and anonymity should be clearly available in the 
pharmacy.  
• Efforts must be made to reassure users that the issues of privacy, 
confidentiality and anonymity are taken seriously and can be appropriately 
addressed by all pharmacy staff. 
                                                 
162 Blenkinsopp, A. Anderson. C. (2003) Consultation areas in community pharmacies: a rapid review of evidence and models 
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3. Developing relationships with stakeholders 
 
 
Pharmacists’  views 
 
Pharmacists are very positive and attach a high degree of importance to health 
improvement activities in the pharmacy and their role in delivering them.  
However, in practice, their approach tends to be reactive rather than proactive and 
centres around the use of medicines rather than a more holistic view of health.  The 
Evidence Base Review, found a number of barriers to developing the pharmacist’s 
role in health improvement, including: lack of remuneration, time pressures, lack of 
training and perceptions of a negative response to these activities by General 
Practitioners and the public.  
 
Recommendations: 
• Address barriers to developing the pharmacist’s role in health improvement 
including: lack of remuneration, time pressures, and perceptions of a negative 
response to these activities by GPs and the public.  
• Develop the pharmacist’s role in health improvement to be proactive and 
centred around a more holistic view of health.   
 
 
Stakeholders’  views 
 
Pharmacy is a valuable component of the multidisciplinary primary healthcare 
team and needs to be recognised and incorporated into it. Likewise, the skill mix in 
the pharmacy needs to be developed.  The Evidence Base Review, found that 
there are inter-professional and logistical barriers to closer working between 
pharmacists and staff working in primary care. In logistical terms, insufficient 
resources for development, support and facilitation locally, have been suggested 
as possible barriers to collaborative working.  In terms of inter-professional 
barriers, research in the 1990s found that, often, the work of community 
pharmacists is viewed as peripheral rather than central to public health and health 
improvement activities. It is up to the profession, through alliances and joint 
working, to develop a vision that relates to local health priorities and needs.  The 
Evidence Base Review, found that pharmacists generally expressed a willingness to 
work more closely with primary care staff but felt uncertain whether their input 
would be welcomed. Primary care staff were predominantly positive about 
community pharmacists’ potential involvement and often expressed confidence in 
individual pharmacists. However, they reported wider anxieties about 
pharmacists’ lack of access to medical records and the commercial aspect of their 
business.  Since this research was conducted, there have been an increasing 
number of community pharmacists who have been working on a sessional basis to 
provide prescribing advice to local practices. Further research is needed to assess 
whether wider integration has occurred as a result of this development. 
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The Evidence Base Review, found that collaborative working is reported to be 
greater where the pharmacy dispenses high numbers of prescriptions, or, is the 
only pharmacy near a GP surgery. This suggests that collaboration is currently 
associated with the existing mode of remuneration for pharmacy services. 
 
Joint training events between pharmacists and Primary Healthcare Team members 
appear to be useful in promoting collaborative working. However, pharmacists 
report finding it difficult to make time to leave the pharmacy and attend ‘team 
meetings’. 
 
Recommendations: 
• Pharmacy needs to be incorporated into the multidisciplinary primary 
healthcare team. 
• Overcome barriers to pharmacy becoming integrated into the wider health 
community such as training and remuneration. 
• Further research is needed to assess whether wider integration has occurred.  
• Joint training events between pharmacists and other health professionals at a 
local level. 
 
 
Pharmacy users’  views -  P u blic perception and expectation 
 
The Evidence Base Review, found that pharmacy users are positive about 
pharmacy-based health improvement activities and value advice and services from 
community pharmacies. For example, community pharmacies are highly rated by 
users as a source of supply and advice for emergency hormonal contraception and 
head lice management. However, public perception of services available through 
pharmacy needs development, since both the public and community pharmacists 
believe, that the advice-giving role of community pharmacists on general health 
issues is not widely recognised or utilised.  The public view pharmacists primarly 
as drugs experts rather than experts on health and illness.  
 
The Evidence Base Review, also found that the use of community pharmacies for 
general health advice is greater among women, respondents with young children 
and those in lower socio-economic groups.  Therefore, pharmacy could play a vital 
role in tacking health inequalities. Further research is required to investigate the 
use of community pharmacies by members of lower socio-economic groups and 
other disadvantaged groups. 
 
Recommendations: 
• Develop public perception of the services available through pharmacy. 
• Investigate how community pharmacies could be used to tackle health 
inequalities.  
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4       Conclusions 
 
Community pharmacists already make a significant contribution to public health 
through their day-to-day activities. However, the public health role of pharmacists 
and their staff could be developed further.  
 
Reports 1 and 2 of the Evidence Base Review, clearly demonstrate the potential of 
community pharmacists to improving the public’s health. The Review found that 
public health initiatives delivered through pharmacies could significantly 
contribute to both local and national strategies and targets.   To this end, it is 
recommended that pharmacy be integrated into the wider primary care and public 
health workforce.  It is also recommended that, where pharmacy-based public 
health initiatives have been found to be effective, they should be incorporated 
into national and local commissioning plans. Further research and pilots need to be 
carried out on other areas where community pharmacy could be effective.   
 
Public awareness of the services available through pharmacy need to be 
developed, particularly among of those who would benefit most from increased 
access to health advice - such as those living in areas of deprivation. 
 
The barriers to expanding the role of the pharmacist to public health practitioner, 
need to be addressed urgently. As well as an appropriate infrastructure support 
established, to enable pharmacy to contribute effectively to the public health 
agenda, in co-operation with other health professionals and related services.  This 
infrastructure support, must include training and education, appropriate 
reimbursement, information technology and redesign of pharmacy premises. 
Comprehensive training and education programmes designed to meet the needs of 
both pharmacy practitioners and public health specialists must be established as a 
matter of priority. These need to be based around the 10 key areas for public 
health practice.  In terms of remuneration, the new pharmacy contract must reward 
high-quality, patient-centred, effective public health interventions and encourage 
the maximum number of pharmacies to engage in public health activities.  
Pharmacy premises must also have facilities available to enable confidential 
consultations, especially when giving advice on sensitive topics.  Once the support 
infrastructure is in place, pharmacists will be able to engage positively and 
effectively with the public health agenda. 
 
Community Pharmacists are a valuable part of the public health workforce and 
must become more integrated with the NHS and wider public health workforce. 
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Ap pendix 
 
Reports 1  and 2 –  Key f indings 
 
Evidence summaries – Where community  pharmacy can be ef fective 
 
Smoking and smoking in pregnancy 
 
Key Findings: 
• Community pharmacists trained in behaviour change methods are effective in 
helping clients stop smoking (B1). 
• Training increases knowledge, self-confidence and positive attitude of 
pharmacists and their staff in relation to smoking cessation (B1). 
• Community pharmacy-based stop smoking services are cost-effective (B1). 
• There is potential benefit to be gained from a whole staff approach in 
community pharmacy, although there is no comparative data for when 
pharmacists alone have provided the service (2). 
 
Stakeholder  responses: 
• Pharmacists are more likely to respond to smokers’ requests for advice than to 
initiate conversations about smoking. (1) 
 
Further research: 
• Further research is needed into the effects of community pharmacy team 
approaches on, service provision capacity, quit rates and numbers of people 
setting a quit date. (2) 
 
 
 
Healthy eating, obesity  and weight red uction 
 
Key f indings: 
• Community pharmacy-based weight reduction programmes appear to show 
promise but further evidence is needed (B3). 
 
Further research: 
• Further research is required to determine the potential for effective weight 
reduction programmes, based in community pharmacies. 
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Coronary Heart  Disease Screening and Management 
 
Lipid  management 
 
Key f indings: 
• Lipid management services provided by community pharmacists are effective 
in 
- Helping clients to achieve target lipid levels (B1). 
- Enhancing the prescribing and use of lipid-regulating medications (B1). 
- Reducing clients’ coronary heart disease risk scores (B1). 
• There is insufficient evidence to determine whether ‘screening’ activities (e.g. 
blood pressure measurement), carried out in community pharmacies, are an 
effective use of resources without further research and training (B3).  
• Using pharmacy medication records to identify clients at ‘high risk’ of coronary 
heart disease is effective and can be used for instigating health promotion 
measures (B1). 
• Information routinely kept by community pharmacies on dispensed medication, 
can also be used for case finding of patients for interventions in lipid 
management (C1).  
 
Further research: 
• Further investigation into the effectiveness and cost-effectiveness of ‘screening’ 
activities in community pharmacies should be carried out. 
 
Aspirin, anticoagulant monitoring and screening 
 
Key Findings: 
• Community pharmacy audits can identify self-initiated aspirin treatment and 
encourage referral for medical advice (B3). 
• Patients taking aspirin prophylactically have unmet information needs that 
could be provided for by community pharmacists (C1). 
• Community pharmacy-based monitoring of the following shows promise but 
more evidence is needed on: 
- The use of prophylactic aspirin treatment (B3). 
- Anticoagulant therapy (B3). 
 
Stakeholder  responses: 
• The pharmacist is perceived by pharmacy users as an appropriate potential 
source of advice on aspirin and heart disease. However, pharmacists are not 
perceived to be currently providing the advice they need by patients taking 
aspirin, partly because patients are often reluctant to ask (C1). 
• There was some concern about the level of privacy achievable in a community 
pharmacy; with just over half believing that the pharmacy was a suitable 
venue for receiving information on aspirin. 
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Further research: 
• Further research, in collaboration with local prescribers is needed, to test 
feasibility and outcomes of a community pharmacy programme to improve 
benefit and reduce harm from prophylactic aspirin use (AB). 
• Further research into community pharmacy-based monitoring of anticoagulant 
therapy is urgently required, to identify the potential for minimising negative 
health outcomes for this ‘high risk’ patient group. 
 
 
 
Skin cancer prevention 
 
Key f indings: 
• Training in skin cancer prevention enhanced knowledge and increased the 
opportunistic offering of advice to clients by pharmacists (B1). 
 
Further research: 
• Pharmacy-based information on skin cancer prevention appears to be effective 
in raising awareness of 'sun risks' and trained pharmacists are more likely to be 
proactive in counselling clients. However, the effects of this advice on 
behaviour are unknown and further research should address this information 
shortfall. 
 
 
 
Oral health 
 
Key Findings: 
• Pharmacists are asked by their customers to give advice on oral health, but 
training received on this topic is variable and evidence of the effectiveness of 
their interventions is lacking (B3). 
• Training and participation in oral health promotion activities appear to increase 
pharmacists’ intent to try to change users’ behaviour (C1). 
• A more proactive approach by pharmacists is required, to maximise 
opportunities for oral health development (C1). 
 
Stakeholder  responses: 
• Most pharmacy customers say they believe sugar-free medicines are important 
for children, but opportunities for pharmacists to recommend sugar-free 
medicines for children are limited, as most requests from customers are for 
named medicines (C1). 
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Diabetes 
 
Key Findings: 
• Pharmacy-based group education for people with diabetes shows promise but 
more evidence is needed (B3). 
• Community pharmacy-based monitoring and information giving, in diabetes, 
shows promise in improving diabetic control, but further research is needed 
(B2). 
 
Further research: 
• Further research into the effectiveness of pharmacy-based programmes to 
improve the management of diabetes should be initiated. 
 
 
 
Asthma 
 
Key Findings: 
• An educational intervention by pharmacists enhances asthma knowledge 
among primary school teachers (B2). 
 
Further research: 
• Further research is required into whether pharmacist-led training programmes, 
can lead to improved management of asthma in schoolchildren by teachers. 
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Prevention of  teenage pregnancy 
 
Key Findings: 
• Emergency contraception can be effectively and appropriately supplied by 
pharmacists (B3). 
• Pharmacy supply of EHC enables most women to receive EHC within 24 hours 
of unprotected intercourse (B3). 
• Window displays in pharmacies are effective in raising client awareness, about 
supply and increasing the presentation of prescriptions for emergency 
contraception and pregnancy tests (B3). 
• A small minority (10%) of women, choose pharmacy supply of EHC in order to 
maintain anonymity (B3). 
• The role of other pharmacy staff in provision of EHC services is reported by 
pharmacists to be important, but there is no data to enable assessment of their 
contribution (B3). 
 
Stakeholder  responses: 
• Users were generally satisfied with the service pharmacists provided (C1). 
• Community pharmacies are highly rated by women as a source of supply and 
associated advice for EHC on prescription, by Patient Group Directions or over-
the-counter sales (B3). 
• Pharmacists were positive about their experience of providing emergency 
hormonal contraception through Patient Group Directions and, over the counter 
sales (B3). 
• Pharmacists wish their services for supply of EHC to develop in order to meet 
women’s needs at a local level, particularly through increased use of Patient 
Group Directions to supply under 16 year olds (B3). 
 
Further research: 
• Further monitoring is needed into the use of, and outcomes of, pharmacy 
supply of EHC under Patient Group Directions. 
• The contribution of other pharmacy staff should be evaluated. 
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Folic acid  and pregnancy 
 
Stakeholder  responses: 
• The attitudes of GPs had an influence on whether pharmacists placed a folic 
acid label on certain products and staff reported feeling more comfortable 
discussing this issue with customers they knew, suggesting it is a sensitive 
topic. 
• Pharmacy staff are positive about promoting the role of folic acid in pregnancy, 
but there is no published evidence of the effects of interventions on behaviour 
(B3). 
 
Further research: 
• Further investigation should be carried out to assess the impact of pharmacy-
based interventions on folic acid use by women. 
 
 
 
Mental health 
 
Key f indings: 
• Community pharmacies are used for the purchase of products to reduce stress 
and anxiety (C1). 
• Pharmacy users take up leaflets on topics relating to stress and anxiety with 
leaflets on sleep problems and relaxation being most commonly selected (C1). 
• Around half of pharmacy staff were aware of relevant local self-help groups 
(C1). 
• At present most pharmacy-based support appears to be linked to medicine 
sales. 
 
Stakeholder  responses: 
• Most (87%) pharmacy users did not regard pharmacists as their preferred 
source of advice on stress and anxiety (C1). 
 
 
 
Further research: 
• Further research is required to determine whether there is a role for pharmacies 
in the management of stress and anxiety. 
 
Drugs misuse 
 
Key f indings: 
• Community pharmacy-based supervised methadone administration services 
can achieve high attendance rates and be acceptable to clients (B3). 
• Positive attitudes among pharmacists are correlated with higher service 
provision for drug users (B3). 
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• Specific training needs have been identified, for pharmacists participating in 
pharmacy-based needle-exchange schemes. Such training needs to include 
skills in translating technical terms into a suitable language for drug users (C1). 
• Pharmacy-based needle-exchange schemes are cost-effective (B3). 
• Cultural barriers (e.g. use of ‘drug culture’ language) are important to address 
through training. 
 
Stakeholder  responses: 
• Most drug users value community pharmacy-based services highly (B3). 
• Practising pharmacists appear to have more negative opinions about drug 
users than undergraduate pharmacy students (B3). 
 
 
Pharmacy P u blic Health Information 
 
Key f indings: 
• Public use of community pharmacies is almost universal but is low for general 
health advice (B3). 
• Passive displays of leaflets may be missed by half of pharmacy customers (C1). 
• Awareness of pharmacy-based leaflets on health topics is higher for those 
clients taking prescribed medicines (B3). 
• Pharmacy window displays are effective in raising client awareness, enquiries 
about supply and the presentation of prescriptions for emergency 
contraception and pregnancy tests (B3). 
 
Stakeholder  responses: 
• Community pharmacists consider leaflets to be an important component of 
their health improvement toolkit (B3). 
 
M ultimedia technology 
 
Key f indings: 
• Multimedia technology (e.g. portable touch-screen kiosks and access to 
electronic information through the Internet) may be a means of engaging young 
and healthy pharmacy customers in health improvement activity (C1). 
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Prevention of  infection 
 
Key f indings: 
• Pharmacists’ knowledge about transmission of HIV, hepatitis B and hepatitis C 
is variable (B3). 
 
Stakeholder  responses: 
• Pharmacists generally have positive attitudes towards involvement in 
prevention of transmission of infection (B3). 
 
Further research: 
• Pharmacists’ current involvement is mainly limited to opportunistic travel 
health advice. The main barriers to increasing their involvement are time, 
remuneration and private consultation areas. Further exploration and research 
into their potential role is urgently required. 
 
 
 
Immunisation 
 
Key f indings: 
• Immunisation services can be provided safely through community pharmacy 
(B3). 
• Support for non-physician delivered immunisation is greater for adult than for 
child immunisation (C1). 
• Pharmacy patient medication records are effective in identifying and flagging 
‘at risk’ clients to be invited for immunisation and can increase the percentage 
of the target group immunised (B3). 
 
Stakeholder  responses: 
• User satisfaction with pharmacy-based immunisation services is high (C1). 
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Head lice 
 
Key f indings: 
• The majority of head lice management programmes require proof of infestation 
before treatment is supplied and between one-quarter and one-third of 
consultations result in no treatment being recommended (B3). 
• Where treatment is supplied, community pharmacists’ adherence to the local 
formulary appears to be extremely high (approaching 100%) (B3). 
• The finding that, no treatment was provided in one-third of cases, indicates 
that pharmacists followed the protocol requirement for examination and proof 
of infection. 
• Work is needed locally to ensure messages about treatment of head lice 
infestation are consistent between pharmacists, GPs, practice staff and schools 
(B3). 
• There is some evidence that the cost of over-the-counter head lice treatments, 
is a barrier to appropriate use. Community pharmacy supply of treatment on 
the NHS should be explored in areas where this applies (C1). 
 
Stakeholder  responses: 
• Pharmacists and health professionals appear positive about the service and 
express a wish for it to continue (B3). 
• User feedback shows that head lice management services are generally well 
received, but between 18% and 34% of scheme users, report having some 
concerns abut privacy in the pharmacy during the consultation (B3). 
• Members of the public see pharmacists as an approachable source of advice 
and treatment for head lice. The provision of this service, however, appears 
unstructured and requires further assessment of its effectiveness. 
 
Further research: 
• No evidence of effectiveness of treatment, or prevention of infestation or re-
infestation was reported in the studies reviewed. Further research to assess the 
effectiveness and cost-effectiveness of these pharmacy-based interventions is 
required, together with the need for local planning and co-ordination of 
treatment services and messages. 
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Sexually  Transmitted Infections  
 
Key f indings: 
• Public interest in the availability of advice on contraception and safe sex 
through pharmacies is high (B3). 
• Pharmacists’ access to up-to-date postgraduate training that incorporates and 
encourages networking with other local service providers, is likely to be crucial 
in increasing pharmacists’ confidence in dealing with these issues appropriately 
and effectively. 
• Pharmacists’ knowledge about transmission of HIV, hepatitis B and hepatitis C 
is variable (B3). 
 
Stakeholder  responses: 
• Quality and confidentiality were identified by pharmacy users as important 
considerations in selecting a pharmacy for advice on women’s health (B3). 
• Pharmacists express support for involvement in promoting safer sex and 
contraception but are rarely asked for such advice and are reluctant to offer it 
(B3). 
• Male pharmacists perceive themselves to be less knowledgeable and more 
embarrassed than female pharmacists, in discussing women’s health issues (B3 
 
 
 
Accidental injury  
 
Key f indings: 
• A pharmacy-based osteoporosis screening service, involving pharmacist and 
nurse input, was found to be feasible and identified women at risk of 
osteoporosis (B3). 
 
Stakeholder  responses: 
Women using the scheme valued the accessibility offered by community pharmacy 
(B3). 
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Medicines related injury  
 
Key f indings: 
• Requests to patients to return unused medicines to the pharmacy, resulted in 
large quantities of excess medicines being identified (C1). 
• Important reasons for excess quantities of medicines in people’s homes include 
changes in therapy, patient deaths and adverse effects. 
• Discussions between local health professionals appear to be useful in making 
changes to prescribing frequency to prevent the accumulation of excess 
medicines (C1). 
• During the normal course of their work pharmacists and their staff have a 
substantial amount of contact with older people (who often have a high 
medicine intake) and people who require repeat dispensing. This places them 
in a good position to be able to identify where the use of medicines may be 
predisposing the user, or carer, to accidents in the home or elsewhere. 
 
Further research: 
• Further research into the pharmacist’s role in preventing accidents in other 
target groups, like children and young people, is also warranted. 
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Factors af fecting the ef fectiveness of  interventions 
Infrastructure sup port 
 
Training  
 
Key f indings: 
 
Training: 
• Training increases pharmacists’ participation in health improvement 
programmes (B3). 
• Training has positive effects on the consultation and information-giving 
behaviour of community pharmacy staff (B1). 
• Training changes pharmacists’ behaviour during specific health promotion 
programmes (B2). 
• Training in health improvement increases the length of consultation between 
pharmacist and client on health issues and increases user satisfaction and 
opportunistic health promotion advice (B2, B3). 
• Postgraduate training produces positive changes in both attitudes and 
behaviour of community pharmacists in relation to health improvement 
activities (B3). 
 
Training and stop smoking services: 
• Training in stop smoking techniques and in behaviour change methods 
increases pharmacists’ effectiveness in achieving higher quit rates (B1). 
• Community pharmacists trained in behaviour change methods are effective in 
helping clients stop smoking (B1). 
• Training increases knowledge, self-confidence and positive attitudes among 
pharmacists and their staff in relation to smoking cessation (B1). 
 
Training and drug use programmes: 
• Specific training needs have been identified for pharmacists participating in 
pharmacy-based needle-exchange schemes (C1). 
• Training for pharmacists needs to include skills in translating technical terms 
into a suitable language for drug users (C1). 
 
Training and oral health initiatives: 
• Pharmacists are asked by their customers to give advice on oral health, but 
training received on this topic is variable and evidence of the effectiveness of 
their interventions is lacking (B3). 
• Training and participation in oral health promotion activities appears to 
increase pharmacists’ intent to change users’ behaviour (C1). 
 
Training and skin cancer prevention: 
• Training in skin cancer prevention enhanced knowledge and increased the 
opportunistic offering of advice to clients by pharmacists (B1). 
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Facil itators 
Key f indings: 
• Support from facilitators increases the number of health improvement 
consultations made by community pharmacists (B3). 
• Support from facilitators was associated with pharmacy-based health 
improvement activities with high public uptake (C1). 
 
 
 
Information Technology 
 
Key f indings: 
• Using pharmacy medication records to identify clients at ‘high risk’ of coronary 
heart disease is effective and can be used for instigating health promotion 
measures (B1). 
• Information routinely kept by community pharmacies on dispensed medication, 
can also be used for case finding of patients for interventions in lipid 
management (C1). 
• Pharmacy patient medication records are effective in identifying and flagging 
‘at risk’ clients to be invited for immunisation and can increase the percentage 
of the target group immunised (B3). 
 
 
 
Design and use of  pharmacy premises 
 
Key f indings: 
• Community pharmacists and users, appear to have different perceptions of 
what constitutes acceptable facilities to maintain privacy (B3). 
• Pharmacy users’ perceived concerns about privacy are generally not borne out 
in their reports of actual experience (B3). 
• Most users of potentially sensitive pharmacy services (e.g. emergency 
hormonal contraception, head lice management) report adequate facilities for 
privacy in community pharmacy, with a consistently sizeable minority (up to 
20%) expressing concern (B3). 
• A sizeable minority (around 20%) of women obtaining emergency hormonal 
contraception from community pharmacies, reported having concerns about 
confidentiality and this was higher among those under 19 years of age (B3). 
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Developing relationships with stakeholders 
 
Pharmacists’  views 
 
Key f indings: 
• Pharmacists are generally very positive about the need for health improvement 
activities in the pharmacy and their role in delivering them.  In practice, 
however, their approach tends to be reactive rather than proactive and centred 
around the use of medicines rather than a more holistic view of health.  A 
reported combination of barriers have been identified including: lack of 
remuneration, time pressures, and perceptions of a negative response to these 
activities by GPs and the public. 
• Dispensing duties and a lack of training, time and space within the pharmacy 
are widely reported to be key barriers to pharmacists’ greater involvement in 
health improvement (B3). 
• Pharmacists attach a high degree of importance to health improvement (B3). 
• Pharmacists are more comfortable with health improvement activities that are 
related to medicines and need support to extend their portfolio of health 
related work (B3). 
• Pharmacists’ concerns about being ‘intrusive’ in offering potentially unwelcome 
health advice predisposes to a reactive stance (B3). 
• Future roles in health improvement are largely perceived as medicines-related 
by community pharmacists (B3). 
 
Further research: 
• Further evaluation of the recently developed services (including means of 
remuneration and time spent in these activities) is necessary, to accurately 
determine the extent to which these reported barriers to community pharmacy 
involvement exist today. 
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Stakeholder  v iews 
 
Key f indings: 
• Recent community pharmacy service developments (e.g. emergency hormonal 
contraception supply, head lice management) were well-received by GPs and 
primary care nurses (B3) 
• The extent of sustained joint working between community pharmacists and 
other members of the primary health care team is generally low but may be 
improved by joint training (B3).  
• Referrals from pharmacists to other health professionals are higher where 
pharmacy staff have knowledge of relevant local services. 
• Collaborative working is reported to be higher where the pharmacy dispenses 
high numbers of prescriptions or is the only pharmacy near a GP surgery. 
• Joint training events between pharmacists and Primary Healthcare Team 
(PHCT) members appear to be useful in promoting collaborative working but 
pharmacists report finding it difficult to find time to leave the pharmacy and 
attend ‘team meetings’. 
 
Stakeholder  v iews: 
• Primary healthcare team members expressed some general anxieties about the 
wider role of community pharmacy in promoting health but reported having 
confidence in individual pharmacists known to them (B3). 
• New community pharmacy service developments, such as EHC and head lice 
management, were well received by primary care health professionals (B3). 
• Pharmacists report isolation from other health professionals as one of the 
barriers to developing sexual health services. 
• Community pharmacists have concerns about the receptiveness of GPs and 
patients to a greater role in health improvement, so their advice is more likely 
to be reactive than proactive. (B3). 
• PHCT members are generally positive about pharmacists’ involvement in 
service development. However, reservations exist around community 
pharmacists’ lack of access to patients’ full medical histories and about 
potential conflicts of interest arising from commercial activities. 
 
Further research: 
• Further investigation is needed into how local health service planners and 
commissioners perceive pharmacy's role in health improvement and its 
contribution to local service plans. 
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Pharmacy user v iews – p u blic perception and expectation 
 
Key f indings: 
• Client feedback from pharmacy-based health improvement projects is 
invariably positive (B3) 
• Both the public and community pharmacists believe that the advice-giving role 
of community pharmacists on general health issues is not widely recognised or 
utilised. Clients’ awareness that community pharmacies are a source of general 
health advice is low (B3) 
• Pharmacy users report having followed the health advice given by pharmacists 
with positive views on the pharmacist’s input (B3). 
• Community pharmacists are perceived as drugs experts rather than experts on 
health and illness (B3). 
• Community pharmacies are highly rated by users as a source of supply and 
advice for emergency hormonal contraception and head lice management (B3). 
• Awareness of pharmacy-based leaflets on health topics is higher for those 
clients taking prescribed medicines (B3). 
• Most pharmacy users perceive there is sufficient privacy in the pharmacy to 
discuss even sensitive subjects (B3). 
• Most clients (80%) report having experienced an acceptable level of privacy for 
their consultation in the pharmacy (C1). 
• Quality and confidentiality were identified by pharmacy users as important 
considerations in selecting a pharmacy for advice on women’s health (B3). 
• A small minority (10%) of women choose pharmacy supply of EHC in order to 
maintain anonymity (B3). 
• User feedback shows that head lice management services are generally well 
received, but between 18% and 34% of scheme users report having some 
concerns about privacy in the pharmacy during the consultation (B3). 
 
Further research: 
• Use of community pharmacies for general health advice is higher among 
women, respondents with young children and those in lower socio-economic 
groups. Further research is required to investigate the use of community 
pharmacies by lower socio-economic and other disadvantaged groups, 
particularly in relation to advice-giving, as well as the supply of medicines. 
 
 
 
 
